rfhg_165457.1

Basic information about the TSS

---

TSS ID: rfhg_165457.1 TSS ID(Version3): hg_139359.1 hg_139358.1 hg_139360.1 Species: human Chr: chr14		Start: 39180543 End: 39180651 Strand: +
Source datasets	FANTOM5|ENCODE|PRJNA401781|PRJNA615891
Protocol	CAGE|SLIC_CAGE
TSS cluster detected*	4

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK304622:-35 GeneID: 5411 HGNC/MGI_ID: HGNC:9162 UniProt_ID: B4E392 Nearer transcript ids and distances:

Gene_name: pinin, desmosome associated protein Gene_symbol: PNN Gene_synonyms: memA Gene_source: HGNC:9162

TATA-Box annotation

---

Distance to TSS:	5343
Nearest PromoterID:	NM_002687
Entrez ID:	5411
Nearest Unigene:	Hs.409965
Nearest Refseq:	NM_002687
Nearest Ensembl:	ENSG00000100941
Gene Name:	pinin, desmosome associated protein
Gene Alias:	DRS|DRSP|SDK3|memA
Gene Type:	protein-coding
CpG%:	0.018519
GC%:	0.449541
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PNN p2@PNN p3@PNN p4@PNN p5@PNN p6@PNN p7@PNN p8@PNN p9@PNN p10@PNN
Sample		p1@PNN	p2@PNN	p3@PNN	p4@PNN	p5@PNN	p6@PNN	p7@PNN	p8@PNN	p9@PNN	p10@PNN
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	115.32	27.66	15.97	11.49	6.43	5.45	7.21	3.70	2.73	2.53
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	108.04	24.48	13.76	11.73	4.65	6.07	3.64	4.45	2.43	2.43
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	129.63	30.86	13.70	14.85	6.94	6.75	6.56	5.59	2.89	3.28
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	96.68	28.48	14.76	4.57	2.29	4.99	6.45	3.95	2.29	2.29
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	114.28	31.95	13.05	8.77	4.50	4.95	4.27	3.82	0.90	2.25
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	112.80	37.79	12.40	9.50	5.23	4.26	5.04	3.88	2.91	1.74
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	125.94	36.60	19.39	10.02	4.14	5.66	7.63	4.36	3.92	4.14
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	96.16	36.82	8.72	6.54	1.94	2.91	5.09	3.39	2.18	1.45
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	77.58	23.51	6.41	6.63	3.42	3.21	3.63	1.07	1.71	1.71
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	101.43	42.89	10.43	2.32	2.32	3.48	2.32	1.16	1.74	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	89.34	44.47	10.51	4.04	3.64	3.23	5.26	1.62	1.21	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	74.81	41.87	6.91	2.44	2.44	0.41	0.41	1.22	1.63	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	40.46	6.13	1.29	2.26	1.45	2.10	1.45	1.61	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	40.44	5.11	2.41	1.20	0.75	1.20	1.20	1.35	1.05	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	42.59	3.73	3.73	1.98	1.54	1.10	1.98	1.76	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	32.95	3.52	1.01	2.77	0.75	0.50	1.26	0.75	0.25	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	31.45	2.84	1.53	1.75	1.09	0.22	2.18	0.22	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	25.73	2.11	1.27	2.95	0.84	1.27	2.11	0.42	0.84	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	38.92	5.33	1.07	2.13	2.67	1.07	0.53	1.07	1.07	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	41.97	3.91	2.56	1.96	0.75	0.90	0.75	1.20	0.75	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	43.97	3.21	2.67	3.21	0.80	1.34	2.41	1.60	0.67	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	49.20	4.66	1.55	1.38	1.73	1.55	1.04	1.38	1.04	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	48.60	4.39	1.94	1.42	1.81	1.16	1.29	1.16	1.29	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	41.01	6.31	4.13	2.91	0.97	0.97	2.43	1.21	1.21	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	40.25	3.10	2.06	1.55	0.52	0.77	2.06	2.32	0.00	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	45.89	3.17	3.17	3.48	0.00	2.53	3.17	2.85	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	35.17	2.75	1.65	3.85	1.10	0.55	0.00	4.40	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	54.22	5.19	4.24	5.89	2.59	3.54	2.83	4.24	1.18	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	37.80	4.52	1.45	2.42	0.97	0.97	0.65	0.97	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	52.48	5.25	1.99	1.99	1.09	0.54	1.45	1.63	0.36	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	31.19	4.19	0.84	1.88	0.84	0.42	0.84	2.30	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	34.39	2.74	0.98	1.17	0.20	0.78	0.98	0.98	0.20	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	38.41	2.95	3.59	4.43	1.27	1.06	0.84	0.84	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	56.57	5.11	2.31	5.28	1.32	2.31	1.81	2.31	0.99	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	37.58	4.67	2.62	2.62	0.93	1.31	1.50	1.50	0.93	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	36.03	3.26	1.92	1.72	0.77	1.53	1.34	0.96	0.96	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	35.36	3.07	1.84	1.64	1.23	1.02	0.82	0.41	0.61	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	35.66	3.22	0.60	1.41	0.20	0.81	0.20	0.40	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	41.33	4.86	0.81	3.24	1.62	1.08	1.08	1.62	0.54	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	37.45	2.64	2.40	2.16	1.68	0.72	1.20	1.92	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	27.76	3.29	0.94	2.35	0.24	0.00	1.18	0.94	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	38.65	4.83	1.17	1.61	0.73	0.73	0.88	1.46	0.44	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	32.06	3.59	0.63	1.69	0.63	0.63	1.69	1.05	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	29.55	3.50	1.05	2.62	1.05	0.52	1.05	1.05	0.35	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	47.98	2.41	1.61	1.00	0.40	0.40	0.60	0.40	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	39.55	2.09	3.02	3.26	1.40	0.47	1.40	2.09	0.70	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	27.59	3.84	0.72	0.96	0.48	0.48	0.72	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	32.19	3.58	0.60	1.49	1.49	0.30	0.89	1.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	26.09	2.87	0.96	0.24	0.72	0.24	0.96	0.00	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	28.31	3.44	1.01	0.40	0.40	0.20	1.21	0.40	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	28.08	2.87	2.46	2.66	1.02	0.00	2.05	0.41	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	31.80	3.56	3.11	4.00	0.67	0.44	1.56	2.45	0.89	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	2126.81	181.90	335.81	83.95	167.91	167.91	125.93	83.95	69.96	55.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	18.45	2.84	2.48	1.42	0.35	0.00	0.71	0.71	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	23.53	2.32	2.32	1.33	0.66	0.33	0.66	0.33	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	229.03	11.75	35.24	26.85	15.10	8.39	23.49	26.01	11.75	5.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	62.00	6.43	7.81	4.59	0.92	0.92	2.30	0.92	0.46	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	23.98	1.62	1.30	1.94	0.32	0.00	0.00	1.30	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	20.23	0.96	2.89	1.61	0.96	0.00	0.96	0.96	0.00	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	52.18	4.40	2.20	3.14	0.94	0.31	1.26	1.89	0.63	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	15.51	4.23	0.71	1.41	0.00	0.00	0.71	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	15.70	1.12	1.12	0.00	1.12	0.56	0.56	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	78.02	3.18	20.70	10.35	2.39	1.59	9.55	7.17	4.78	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	29.22	1.02	5.10	1.02	1.70	1.02	0.68	0.34	1.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	16.90	4.22	0.65	1.62	0.65	0.32	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	20.23	1.06	0.71	1.06	0.35	0.35	1.42	2.13	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	2440.75	177.80	242.46	80.82	48.49	129.31	96.98	64.66	48.49	96.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1224.11	94.77	157.95	110.56	63.18	47.38	23.69	55.28	55.28	23.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	19.50	0.98	0.98	2.93	0.49	1.46	0.00	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	17.85	0.50	1.49	1.98	0.00	0.00	0.50	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	13.60	2.35	1.88	0.00	0.47	0.47	0.47	0.47	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	24.84	3.31	1.99	0.99	0.33	0.33	0.66	0.33	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	19.80	3.71	1.24	0.62	0.00	0.62	0.93	0.31	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	13.15	3.06	1.22	1.83	0.92	0.00	0.31	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	32.94	3.96	0.79	0.95	0.79	1.11	1.27	0.95	0.79	0.32
Adipocyte - breast, donor2	11327-117E4	30.00	4.65	3.37	3.21	2.73	2.09	3.21	1.28	1.28	0.96
Adipocyte - omental, donor1	11473-119C6	38.04	5.34	0.76	0.76	1.02	0.51	0.51	0.38	0.51	0.00
Adipocyte - omental, donor2	11474-119C7	26.91	1.49	0.00	3.74	0.75	0.00	0.00	0.00	1.49	1.49
Adipocyte - omental, donor3	11475-119C8	24.11	3.01	0.67	1.67	0.67	0.67	0.33	0.00	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	19.78	5.10	1.91	0.00	0.00	0.00	0.00	0.00	0.00	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	7.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	13.55	2.71	0.90	0.45	0.00	0.90	0.00	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	9.21	2.26	0.70	0.17	0.52	0.35	0.52	0.17	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	55.15	5.87	0.59	0.20	0.98	1.17	0.59	0.39	0.39	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	32.17	5.40	1.80	1.29	1.54	0.26	0.51	0.51	0.51	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	21.19	6.13	1.12	0.56	0.00	0.28	0.28	0.28	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	38.80	2.94	0.00	0.00	0.59	0.59	0.59	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	63.70	8.04	1.21	0.88	0.64	1.13	0.32	0.64	0.32	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	35.50	6.13	0.00	0.32	1.29	0.65	0.65	0.00	0.32	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	26.13	3.73	2.13	1.07	0.00	0.00	1.07	0.53	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	30.05	2.78	1.11	1.11	0.00	0.56	0.00	0.56	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	17.05	2.91	0.42	0.83	0.42	0.42	0.00	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	19.34	3.01	0.75	0.75	0.00	0.00	0.75	0.25	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	23.56	2.62	1.31	0.33	0.33	0.65	0.33	0.33	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	26.18	1.83	0.61	0.30	0.00	0.00	0.30	0.30	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	8.62	0.88	0.00	0.00	0.00	0.00	0.00	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	5.02	2.15	0.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	11.33	1.80	0.36	0.18	0.18	0.00	0.18	0.00	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	0.00	1.67	0.00	0.00	0.00	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	8.01	0.82	0.41	0.21	0.00	0.00	0.00	0.00	0.41	0.41
Anulus Pulposus Cell, donor1	11248-116E6	9.04	2.75	0.23	0.46	0.23	0.34	0.11	0.11	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	4.41	1.47	0.24	0.00	0.24	0.49	0.00	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	20.67	3.59	1.80	1.80	0.45	0.90	0.45	0.45	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	21.27	2.17	3.47	4.34	1.74	2.17	1.30	0.87	0.43	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	4.28	2.14	4.28	4.28	8.56	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	20.63	4.48	3.29	3.29	1.79	1.20	1.49	0.00	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	20.23	2.53	2.53	2.53	1.26	0.00	0.00	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	8.58	1.32	0.66	1.32	0.00	1.32	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	18.19	2.92	0.32	1.30	0.65	0.65	0.00	0.32	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	24.76	3.40	1.94	1.46	1.94	1.94	1.46	0.00	1.46	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	10.10	2.38	1.78	1.78	1.78	0.00	1.19	1.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	24.86	4.52	1.88	1.88	1.88	0.75	0.38	1.13	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	22.50	2.90	2.18	5.08	2.18	0.73	0.00	0.73	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	0.00	1.25	1.25	1.25	2.51	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	22.07	5.77	0.00	0.33	0.00	0.49	0.16	0.16	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	19.11	9.55	1.36	1.36	1.36	1.36	1.36	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	11.76	2.11	0.00	0.45	0.15	0.15	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	17.68	2.68	1.07	1.07	0.54	0.54	0.54	1.07	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	14.36	3.97	0.57	0.94	0.57	0.57	0.00	0.57	0.19	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	15.50	2.67	4.54	3.47	1.60	2.14	0.53	0.80	0.27	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	18.53	0.00	0.00	0.98	1.95	1.95	2.93	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	19.24	3.98	0.17	1.00	1.00	0.33	0.17	0.50	0.00	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	10.81	2.40	2.40	2.40	0.00	0.00	0.00	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	14.92	4.12	2.23	1.89	0.34	2.23	0.51	1.20	0.86	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	0.00	4.19	0.00	4.19	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	24.76	3.40	2.91	2.91	2.43	0.00	0.49	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	18.97	3.42	2.28	2.28	0.76	0.38	0.76	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	2.42	1.21	2.42	0.00	1.21	0.00	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	19.38	3.99	1.14	1.14	0.00	1.14	0.00	1.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	18.17	2.78	1.28	2.14	0.64	1.28	0.64	0.86	0.43	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	10.32	4.39	0.26	1.29	0.26	0.77	0.00	0.52	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	22.52	3.28	0.94	0.94	0.00	0.47	0.00	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	12.54	2.89	2.25	2.57	1.61	0.96	1.29	1.61	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	12.13	1.43	0.71	0.71	0.00	0.00	0.00	0.71	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	14.04	2.34	0.00	5.85	0.00	0.58	0.00	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	16.86	4.22	1.20	1.51	0.30	1.20	0.00	0.60	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	7.13	2.38	1.19	1.19	1.19	0.00	1.19	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	22.38	2.03	2.03	1.53	2.54	1.02	1.53	0.00	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	21.65	4.33	2.55	1.27	1.53	1.27	1.27	0.51	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	3.81	0.64	0.00	0.00	0.64	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	20.71	1.29	1.73	1.29	0.43	0.43	0.86	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	16.51	3.81	0.85	0.85	0.85	1.06	0.64	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.83	2.61	0.87	1.74	0.58	0.29	0.58	0.87	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.01	2.83	2.83	3.78	1.89	0.00	0.94	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	18.31	2.03	1.70	0.68	0.68	0.51	1.36	0.51	1.02	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	2.32	2.32	6.95	0.00	2.32	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	19.01	2.11	0.00	0.00	0.00	2.11	4.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	16.08	3.65	1.29	1.29	0.86	0.86	0.64	0.00	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	14.44	4.81	0.60	1.20	0.00	0.60	1.20	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	14.58	5.10	0.00	2.19	0.73	2.19	0.00	0.00	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	17.24	3.68	1.15	0.69	1.15	0.69	0.46	0.46	0.46	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	2.55	5.10	5.10	5.10	2.55	0.00	7.65	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	13.98	4.32	0.00	0.00	0.00	0.25	0.00	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	23.33	4.95	1.65	1.03	0.41	1.45	1.03	1.24	0.62	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.93	3.37	1.22	2.14	0.61	0.92	0.31	0.92	0.61	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	21.51	2.87	1.43	2.87	1.91	1.43	1.43	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.08	2.22	2.00	2.44	0.22	0.00	0.00	1.33	0.67	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	6.10	3.05	0.00	1.53	1.53	1.53	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	13.85	3.32	1.11	2.22	0.00	1.11	0.00	0.00	1.11	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	17.21	2.38	2.38	2.38	1.59	1.32	0.53	0.79	0.53	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	10.54	2.18	2.18	2.54	0.36	0.00	0.00	0.36	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	21.74	1.47	0.74	0.25	0.25	0.25	0.00	0.12	0.37	0.00
Astrocyte - cerebellum, donor2	11580-120F5	9.24	2.91	0.00	0.00	0.00	0.51	0.00	0.17	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	5.87	1.05	0.00	0.00	0.21	0.21	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	92.03	11.85	2.44	3.83	1.74	1.74	1.74	0.70	0.00	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	80.56	9.87	7.77	5.99	6.15	3.24	3.72	2.43	3.40	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	87.41	8.80	4.33	2.54	2.09	2.24	1.04	1.34	1.34	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	183.27	35.32	11.81	6.88	7.23	8.14	8.83	4.93	5.28	5.39
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	194.31	31.07	15.28	7.64	9.90	7.27	7.27	4.89	4.76	5.51
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	195.16	29.02	12.06	5.80	8.08	7.17	9.56	3.87	4.44	4.10
Basophils, donor1	12241-129G9	41.85	9.68	0.00	0.52	0.00	0.00	0.26	0.00	0.00	0.00
Basophils, donor2	12242-129H1	149.01	25.26	0.36	1.44	0.00	0.36	0.00	0.72	0.72	0.00
Basophils, donor3	12243-129H2	46.45	10.29	0.88	0.29	0.73	0.59	0.29	0.15	0.44	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	4.74	1.08	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.74	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	11.30	3.77	0.00	0.00	0.00	0.63	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	6.65	3.33	0.21	0.00	0.21	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	4.84	4.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	24.29	10.98	5.04	5.40	3.42	3.78	2.88	1.80	2.52	2.16
Burkitt's lymphoma cell line:DAUDI	10422-106C8	247.85	44.62	11.95	7.63	7.73	7.21	7.83	5.26	4.64	3.30
Burkitt's lymphoma cell line:RAJI	10476-106I8	341.90	57.99	25.62	16.54	13.28	11.18	10.95	8.38	5.82	4.66
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	184.83	28.14	0.32	2.24	0.32	0.00	0.00	1.28	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	599.83	72.39	10.34	0.00	0.00	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	122.86	27.61	0.56	1.13	0.56	2.25	1.13	1.13	0.56	1.13
CD14+ Monocytes, donor2	11305-117B9	124.54	37.12	10.21	6.31	12.06	8.17	7.24	5.38	6.12	4.83
CD14+ Monocytes, donor3	11381-118B4	102.30	30.52	8.12	7.03	8.12	8.78	4.17	4.17	6.15	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	49.25	12.17	0.28	0.28	0.85	0.28	0.57	0.85	0.28	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	62.17	7.20	0.38	1.14	1.14	0.38	0.76	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	64.43	10.52	1.64	0.33	0.33	1.31	0.99	0.33	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	48.13	10.12	3.18	2.75	3.47	4.05	2.75	2.31	2.31	1.45
CD14+ monocytes - mock treated, donor2	11873-125C1	50.39	11.16	0.91	1.81	2.41	1.21	2.72	2.11	3.62	1.51
CD14+ monocytes - mock treated, donor3	11883-125D2	66.09	13.98	0.95	1.18	4.03	4.03	1.90	0.95	2.13	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	33.65	11.22	2.85	1.34	2.18	2.34	2.18	1.34	1.84	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	41.68	7.73	2.48	1.10	3.04	2.76	2.76	2.21	2.48	1.66
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	56.53	16.61	3.47	2.48	5.21	3.97	2.23	1.24	2.73	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	24.87	9.59	1.17	0.98	1.57	3.13	1.37	0.98	0.59	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	28.84	9.61	1.60	0.71	2.14	2.31	2.31	1.42	1.25	1.25
CD14+ monocytes - treated with BCG, donor3	11880-125C8	52.67	12.19	0.65	0.44	0.65	1.09	0.44	0.65	0.44	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	34.88	15.22	1.40	1.64	1.17	1.64	1.64	1.40	0.47	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	75.51	22.71	3.17	0.53	3.70	8.98	2.64	1.06	2.64	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	61.01	24.41	3.33	1.11	1.11	0.00	0.00	0.00	3.33	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	48.49	11.30	2.38	3.57	4.02	4.02	2.83	3.42	4.31	1.34
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	48.29	8.18	2.79	2.00	3.39	4.59	2.59	2.20	2.20	1.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	71.83	11.24	2.29	0.42	0.83	2.29	1.04	0.42	0.62	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	30.43	11.21	1.83	2.97	1.37	2.75	2.06	1.37	0.92	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	47.96	13.57	0.90	0.68	0.45	0.90	0.45	0.23	0.90	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	40.59	11.35	3.93	1.75	1.75	3.06	0.87	0.87	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	29.59	7.80	1.61	1.08	0.54	2.15	0.81	0.00	0.27	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	40.47	6.98	3.66	2.09	4.71	4.36	1.40	1.05	3.31	1.40
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	46.71	11.36	2.10	2.52	2.52	2.10	2.95	1.68	2.10	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	31.78	12.31	4.41	4.78	3.31	3.31	3.31	4.23	1.84	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	39.45	14.09	2.11	0.70	2.82	3.87	2.11	0.70	1.06	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	58.79	17.11	2.63	2.19	3.07	2.63	2.63	0.00	1.75	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	33.83	12.03	6.28	4.18	5.41	4.36	5.93	3.66	3.84	2.27
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	47.95	15.61	7.43	5.95	6.69	4.09	6.69	6.32	4.83	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	85.36	15.95	1.72	0.65	2.16	2.59	1.08	0.65	1.29	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	32.76	6.55	2.87	2.46	3.28	1.64	2.05	1.23	1.23	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	53.78	13.68	0.93	0.23	0.93	1.16	0.70	0.00	0.70	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	55.68	12.76	2.09	0.70	0.70	0.46	0.23	0.46	0.46	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	71.06	17.00	1.09	0.87	0.65	0.22	0.22	0.65	0.00	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	70.22	18.48	2.77	2.08	1.39	0.23	0.23	1.15	0.69	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	61.52	17.11	0.87	1.73	0.65	0.43	0.22	0.87	0.65	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	93.59	22.89	3.11	3.89	1.25	2.02	1.56	2.02	0.62	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	91.34	21.48	1.92	3.32	1.92	0.87	1.57	1.05	0.52	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	188.85	45.93	4.91	2.45	5.80	4.24	3.34	2.68	4.01	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	46.70	16.08	0.26	2.30	0.51	0.51	0.51	1.02	0.00	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	57.09	21.74	1.10	4.39	0.66	0.66	1.10	0.44	0.88	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	56.22	23.58	0.42	1.68	0.63	0.42	0.42	0.42	0.42	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	132.10	16.26	0.00	2.03	0.00	0.00	0.00	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	163.39	20.34	0.00	5.42	2.71	0.68	1.36	1.36	0.68	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	132.56	18.64	3.11	1.04	0.00	0.00	0.00	1.04	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	132.19	8.53	0.00	2.67	1.07	0.53	0.00	1.60	1.60	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	172.08	19.30	1.07	2.68	0.54	1.61	1.07	0.00	1.61	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	146.71	17.55	0.00	2.11	1.40	0.00	0.70	0.00	1.40	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	135.69	11.77	0.78	1.57	0.78	0.78	1.57	0.00	2.35	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	151.60	23.73	1.32	5.27	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	210.41	37.81	15.62	17.26	12.33	11.51	8.22	6.58	11.51	6.58
CD19+ B Cells, donor2	11624-122B4	174.10	28.29	8.71	11.61	8.71	7.25	2.18	2.90	2.90	3.63
CD19+ B Cells, donor3	11705-123B4	175.17	22.72	10.60	8.08	8.58	8.08	2.52	7.57	6.06	4.54
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	200.82	24.24	11.31	4.85	4.04	3.64	3.64	1.21	1.21	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	133.83	15.18	1.20	2.80	1.60	2.80	0.40	0.00	1.20	1.60
CD34+ Progenitors, donor1	11545-120B6	181.73	22.09	0.00	2.01	0.00	0.00	0.00	0.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	241.02	25.28	0.56	2.25	1.69	1.12	0.00	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	173.97	25.55	1.50	7.14	1.13	1.13	0.75	1.88	0.00	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	226.16	34.27	0.68	1.35	0.90	1.13	0.90	0.68	0.90	0.23
CD4+ T Cells, donor1	11225-116C1	291.00	46.42	4.64	3.21	5.00	5.36	5.36	3.21	4.28	3.57
CD4+ T Cells, donor2	11306-117C1	194.73	40.42	12.86	26.33	12.86	11.02	5.51	7.96	9.80	5.51
CD4+ T Cells, donor3	11382-118B5	127.49	22.26	14.94	10.37	7.32	7.93	3.35	6.40	7.93	3.05
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	121.49	15.06	1.53	2.30	2.81	3.32	1.79	1.02	2.04	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	115.89	16.84	2.70	1.80	1.12	1.57	2.02	1.35	1.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	121.02	15.81	1.15	1.15	1.72	1.44	1.72	1.15	0.86	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	181.58	33.19	3.32	3.32	2.37	1.90	1.90	1.42	1.90	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	182.60	51.97	2.11	9.83	2.11	1.40	1.40	1.40	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	171.40	32.96	0.00	6.59	3.30	0.00	0.00	6.59	0.00	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	103.33	12.86	1.59	1.01	3.47	2.60	1.01	1.59	1.88	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	75.24	12.03	6.95	4.74	3.90	4.58	2.03	3.90	3.73	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	70.12	14.99	7.09	4.67	5.16	3.87	3.22	2.42	1.77	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	123.28	14.35	0.45	3.14	1.79	2.24	0.45	1.34	1.79	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	135.56	20.96	2.10	6.29	1.05	1.40	0.70	0.70	1.75	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	250.35	32.12	5.72	5.72	6.60	7.92	3.96	3.08	2.20	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	204.07	16.87	2.95	4.22	5.48	5.90	3.37	2.11	2.11	3.37
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	95.99	16.21	13.09	10.80	5.61	4.78	4.99	5.82	2.70	2.49
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	81.19	11.36	8.02	6.01	3.01	3.01	2.67	4.34	2.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	208.85	40.25	8.70	9.52	4.35	5.71	5.44	2.72	4.08	2.72
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	311.39	57.88	3.75	5.36	4.82	2.68	2.68	2.14	1.07	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	227.74	59.18	7.17	8.97	5.38	3.59	7.17	14.35	3.59	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	146.67	15.21	4.08	3.71	2.41	1.67	1.48	1.67	1.30	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	88.81	9.31	2.60	2.60	1.73	1.52	0.87	0.65	1.52	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	105.50	10.93	2.94	2.10	2.10	1.05	2.52	1.05	0.21	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	152.69	25.79	2.53	6.57	2.02	2.02	0.00	2.02	2.02	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	165.94	22.53	1.73	1.73	1.30	1.73	2.60	0.43	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	329.48	34.87	10.02	7.84	6.10	7.41	4.79	2.18	4.36	4.36
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	152.91	32.17	0.49	1.48	0.00	0.99	1.48	0.49	1.48	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	117.24	20.31	1.85	3.69	0.00	0.92	0.00	0.92	0.92	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	107.48	15.35	1.40	1.40	0.00	0.00	0.00	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	204.10	32.12	1.38	1.38	0.00	1.11	0.83	0.28	0.83	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	246.13	40.00	1.23	3.19	2.21	2.21	0.74	0.74	1.47	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	123.20	27.72	0.00	1.54	1.54	0.00	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	191.59	29.01	1.07	2.15	0.36	1.43	1.07	0.36	1.79	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	153.73	24.93	4.15	1.38	0.00	0.00	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	205.60	31.43	4.58	5.24	2.95	1.96	0.33	3.27	2.29	2.62
CD8+ T Cells, donor2	11307-117C2	153.55	28.16	16.52	14.64	10.89	13.14	9.76	7.13	6.76	6.01
CD8+ T Cells, donor3	11383-118B6	206.03	40.90	16.16	14.64	13.89	13.89	7.32	11.87	8.33	9.34
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	63.54	11.70	7.57	2.52	4.13	3.21	3.90	3.44	2.29	1.84
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	52.00	9.11	7.43	6.47	4.79	1.44	3.12	3.12	1.92	2.40
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	53.08	10.40	7.39	5.47	3.83	3.28	5.47	2.74	3.28	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	80.16	15.91	5.40	3.90	2.40	3.00	2.70	2.10	0.60	1.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	54.72	9.60	8.40	3.60	4.32	2.64	3.12	1.44	1.20	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	43.66	11.82	5.46	1.14	2.27	2.50	2.05	1.36	2.05	1.36
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	51.50	7.82	3.91	3.69	2.61	1.30	1.96	0.87	1.09	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	53.69	10.00	3.16	2.11	3.16	1.84	2.90	0.26	0.53	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	49.48	7.97	5.39	3.75	3.75	2.11	1.17	0.94	1.64	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	69.13	12.98	8.45	6.04	4.53	3.32	3.32	1.51	1.51	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	54.32	6.97	9.59	5.52	3.20	4.07	3.20	2.32	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	55.42	9.86	3.20	2.93	2.93	1.07	1.07	0.53	0.80	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	42.46	10.94	0.00	0.00	0.00	0.00	1.31	0.44	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	34.61	10.02	0.46	0.46	0.00	0.46	0.46	0.00	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	22.38	8.20	0.75	0.00	0.00	0.00	0.00	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	48.98	10.44	1.80	1.44	1.80	2.52	0.72	2.16	1.08	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	47.47	9.21	5.18	1.73	0.86	1.73	2.59	0.86	1.15	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	37.00	9.90	3.77	0.24	1.18	0.47	2.12	0.24	0.24	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	69.09	14.58	10.14	4.75	1.27	2.22	1.58	2.54	1.27	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	62.44	13.23	4.31	3.38	1.85	0.62	1.23	0.00	0.92	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	56.10	11.86	4.17	2.24	0.00	1.28	0.64	0.64	1.28	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	57.75	10.33	3.44	2.68	1.53	3.06	1.53	1.53	0.38	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	44.53	12.61	3.55	2.76	1.97	2.36	0.79	0.79	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	42.36	13.62	5.29	1.51	0.76	0.76	3.78	0.00	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	77.89	31.32	4.01	1.61	2.41	2.41	2.41	0.00	0.00	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	83.93	23.08	9.79	4.20	2.80	2.80	2.80	0.70	0.70	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	98.17	42.07	4.01	7.01	1.00	2.00	4.01	1.00	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	38.38	3.66	3.66	1.83	1.83	1.83	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	14.82	1.48	2.47	0.00	0.49	0.00	0.99	0.49	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	17.89	2.10	0.21	0.00	0.11	0.21	0.21	0.00	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	28.43	4.51	1.73	0.00	0.69	1.39	0.35	0.00	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	8.88	0.71	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	19.57	2.73	2.73	2.05	1.82	1.37	0.57	0.91	0.57	0.46
Chondrocyte - re diff, donor2	11339-117F7	45.66	2.69	0.00	0.00	0.90	0.00	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	19.01	5.66	0.40	0.81	0.00	0.00	0.40	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	100.30	7.80	2.52	3.21	0.92	1.49	0.92	1.84	1.15	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	48.10	4.70	3.85	4.49	2.14	2.78	2.35	1.07	2.14	1.71
Ciliary Epithelial Cells, donor3	11399-118D4	54.25	5.31	5.84	4.25	3.45	2.83	1.68	1.68	1.86	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	30.99	7.24	1.65	0.64	0.92	0.64	0.37	0.55	0.55	0.09
Corneal Epithelial Cells, donor1	11526-119I5	3.95	1.54	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	10.24	2.28	2.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	8.18	2.05	0.26	0.00	0.00	0.00	0.00	0.51	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	36.98	4.29	0.33	0.83	0.33	0.33	0.50	0.50	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	30.59	5.36	0.32	1.26	0.00	0.00	0.32	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	6.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	29.27	5.18	1.62	1.51	1.19	1.30	1.30	0.76	0.43	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	222.41	17.77	3.76	4.78	1.71	1.02	2.39	1.02	1.37	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	219.36	15.02	1.31	0.65	0.00	0.00	0.65	1.31	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	248.26	23.71	1.45	2.90	0.48	0.97	0.97	0.00	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	18.01	1.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	7.04	2.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	13.86	1.70	0.57	0.00	0.28	0.00	0.00	0.28	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	11.01	3.54	0.00	0.00	0.00	0.00	0.39	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	20.94	2.04	0.87	0.87	0.29	0.58	0.29	0.29	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	28.94	7.06	1.65	3.53	1.18	2.35	1.88	0.94	0.24	1.41
Endothelial Cells - Artery, donor3	11413-118E9	15.78	5.43	0.35	0.00	0.00	0.00	0.18	0.00	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	51.20	8.87	0.89	0.89	0.89	0.66	0.00	0.89	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	49.60	8.22	0.00	0.30	0.91	0.00	0.91	0.00	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	63.15	12.40	0.85	0.56	1.97	1.69	1.13	0.28	0.28	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	13.37	1.78	0.30	0.00	0.30	0.30	0.30	0.00	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	11.45	2.08	0.52	0.00	0.00	0.00	0.00	0.00	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	16.31	3.69	2.27	1.84	0.85	0.43	0.71	0.85	0.28	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	61.22	9.20	1.60	0.40	0.80	1.60	0.00	0.80	0.80	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	17.30	2.62	0.00	0.00	1.05	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	109.96	19.51	1.86	1.12	1.12	0.75	1.24	0.75	0.75	0.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	61.27	16.73	1.74	1.52	0.65	0.43	1.09	0.43	0.87	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	85.49	18.56	1.22	1.34	1.22	0.85	0.37	0.12	0.49	0.49
Endothelial Cells - Vein, donor1	11267-116G7	14.79	4.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	11.18	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	20.10	4.55	0.00	0.63	0.47	0.79	0.16	0.00	0.31	0.47
Eosinophils, donor1	12244-129H3	137.22	60.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	145.22	46.21	1.65	1.65	1.65	1.65	1.65	0.00	3.30	0.00
Eosinophils, donor3	12246-129H5	114.14	39.24	0.00	0.00	3.57	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.66	1.47	0.24	0.24	0.00	0.00	0.00	0.24	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	6.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	22.99	3.69	1.64	1.23	0.41	1.64	2.87	1.23	1.23	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.94	1.97	0.44	0.11	0.11	0.11	0.33	0.11	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	7.04	0.98	0.54	0.43	0.11	0.11	0.22	0.11	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	52.64	7.28	1.58	1.94	1.33	0.36	0.97	0.73	0.85	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	180.14	24.70	3.28	4.37	2.59	3.00	1.91	2.46	1.91	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	25.21	4.22	2.64	2.00	1.48	1.05	1.90	1.58	0.74	0.84
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	103.82	10.01	4.74	8.43	3.95	5.80	1.84	0.79	1.84	2.37
Fibroblast - Aortic Adventitial, donor3	11401-118D6	45.84	4.65	4.32	5.65	1.33	3.99	1.00	1.00	0.66	1.33
Fibroblast - Cardiac, donor1	11268-116G8	16.33	1.36	0.00	0.00	0.00	1.36	0.00	0.00	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	12.89	1.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	17.35	2.05	1.58	1.89	0.63	0.63	0.95	0.32	0.47	0.32
Fibroblast - Cardiac, donor4	11452-119A3	70.32	7.27	0.61	0.30	0.30	0.61	0.30	0.61	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	37.94	7.99	1.40	0.76	0.25	0.38	0.13	0.25	0.38	0.51
Fibroblast - Cardiac, donor6	11460-119B2	40.32	6.67	0.61	0.91	0.15	0.76	0.45	0.00	0.61	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	17.15	1.88	0.13	0.00	0.27	0.13	0.13	0.00	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	22.87	1.73	1.73	0.43	1.29	0.86	0.00	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	23.44	1.46	7.32	8.79	4.39	7.32	5.86	5.86	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	11.99	3.69	0.23	0.23	0.00	0.46	0.23	0.00	0.00	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	27.48	2.88	1.36	0.17	0.34	0.85	0.51	0.68	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	21.13	5.17	0.94	0.23	0.94	0.70	0.23	0.94	0.00	0.47
Fibroblast - Dermal, donor2	11346-117G5	12.26	3.30	0.47	0.00	0.00	0.00	0.00	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	19.22	3.99	2.54	2.54	2.30	1.57	0.85	0.48	0.97	0.60
Fibroblast - Dermal, donor4	11450-119A1	43.18	8.48	0.23	0.90	0.11	0.45	0.11	0.23	0.00	0.23
Fibroblast - Dermal, donor5	11454-119A5	54.08	12.21	1.74	0.70	1.05	0.00	0.17	0.17	0.35	0.70
Fibroblast - Dermal, donor6	11458-119A9	59.28	13.64	1.14	2.60	0.81	0.81	0.65	0.65	0.49	0.16
Fibroblast - Gingival, donor1	11237-116D4	49.56	10.62	0.42	0.00	1.04	0.42	0.21	0.00	0.42	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	38.78	4.19	1.05	1.05	0.79	0.26	0.79	0.79	0.52	0.52
Fibroblast - Gingival, donor2	11318-117D4	53.90	9.88	7.38	7.12	3.69	3.29	1.98	1.98	1.45	1.71
Fibroblast - Gingival, donor3	11394-118C8	41.29	9.77	0.29	0.19	0.39	0.10	0.29	0.48	0.68	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	24.93	6.23	0.00	0.00	0.00	1.04	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	20.44	3.00	3.17	1.59	1.94	0.88	1.23	0.70	0.18	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	56.90	6.55	3.12	1.25	1.87	1.25	1.40	0.78	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	40.03	6.76	2.43	1.62	0.68	0.41	0.54	0.68	0.41	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	16.94	3.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	33.05	4.97	0.73	1.02	0.58	0.88	0.44	0.29	0.58	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	51.41	5.73	2.73	1.36	1.50	2.05	2.05	0.55	0.68	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	54.74	9.10	1.54	1.43	0.88	1.21	1.43	1.10	0.77	1.10
Fibroblast - Gingival, donor9 (control)	11927-125I1	38.01	6.75	0.44	0.73	1.03	1.03	0.59	0.73	0.15	0.73
Fibroblast - Lung, donor1	11270-116H1	2.72	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	28.35	2.98	0.00	1.49	0.00	2.98	0.00	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	24.69	4.01	0.21	0.42	0.21	0.63	0.63	0.63	0.42	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	7.50	0.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	1.40	0.00	0.00	0.00	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.68	1.12	0.00	0.00	0.00	0.00	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	25.58	2.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	11.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	61.49	8.73	2.52	1.36	0.78	0.39	0.58	0.78	0.78	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	85.55	13.50	1.67	1.97	2.12	1.52	1.67	0.30	1.06	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	93.33	14.69	0.31	0.00	0.31	0.31	1.53	0.00	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	26.33	5.34	1.14	1.53	0.76	0.76	0.38	0.38	0.38	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	22.41	4.05	0.81	2.43	0.54	0.00	0.27	0.00	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.28	4.75	0.35	0.58	0.35	0.35	0.46	0.00	0.58	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	29.95	4.75	0.22	0.88	0.55	0.22	0.33	0.33	0.22	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	12.19	1.22	0.20	0.00	0.00	0.20	0.81	0.00	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	11.36	1.34	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	11.47	2.77	0.40	0.00	0.40	1.58	0.00	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	131.37	13.30	9.72	11.31	7.34	7.94	5.95	4.56	2.58	4.17
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	37.48	3.55	1.78	1.60	0.53	1.60	1.60	1.24	0.71	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	44.34	3.74	3.15	1.38	1.18	2.17	1.58	0.79	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	98.68	10.83	5.72	5.72	3.31	8.12	3.31	2.41	1.20	1.81
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	61.64	5.40	1.08	1.30	1.19	0.32	0.32	0.65	0.97	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	88.07	13.16	2.78	5.31	3.04	4.05	2.02	0.76	0.76	2.78
Fibroblast - skin normal, donor1	11553-120C5	26.58	1.64	1.15	0.49	0.66	0.66	0.16	0.16	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	197.50	24.86	9.02	5.41	6.62	5.81	4.01	3.61	5.21	1.00
Fibroblast - skin normal, donor2	11561-120D4	47.52	4.72	1.00	0.60	0.40	0.40	0.90	0.20	0.60	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	93.09	10.58	7.25	6.04	3.32	3.63	2.42	2.72	2.12	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	36.37	3.73	0.50	0.58	0.50	0.41	0.33	0.25	0.33	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	53.85	5.47	1.88	1.54	1.03	1.20	1.20	1.03	0.85	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	104.77	10.51	6.57	4.93	5.91	8.21	2.63	1.64	2.30	1.97
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	46.76	3.94	0.53	0.85	0.85	0.85	0.53	0.32	0.53	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	27.33	2.70	1.01	1.01	0.51	1.01	0.51	0.84	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	11.60	0.31	0.63	0.78	0.00	0.31	0.31	0.00	0.63	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	576.15	88.64	44.32	44.32	0.00	22.16	22.16	0.00	0.00	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	61.88	14.82	0.87	0.00	0.87	1.74	2.61	0.00	0.87	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	22.71	4.16	0.35	0.17	0.00	0.35	0.00	0.00	0.35	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	36.17	5.73	0.26	1.30	1.04	0.52	0.52	0.78	0.78	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	43.69	8.43	0.51	0.00	0.26	0.26	0.77	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	52.06	3.83	1.53	2.30	0.77	1.53	0.00	0.77	0.00	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	57.43	5.74	1.91	1.28	1.28	0.00	0.64	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	189.42	25.96	16.26	17.69	11.98	10.84	7.70	7.70	3.71	2.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	143.39	35.02	20.41	25.37	16.27	15.44	14.06	7.17	7.45	5.79
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	113.48	25.80	9.13	12.10	8.45	5.71	10.73	4.34	3.65	2.51
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	117.09	19.81	16.05	12.28	7.93	5.94	7.93	4.95	2.97	1.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	131.90	29.61	16.92	17.18	10.04	10.31	11.63	4.76	2.64	4.49
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	129.81	24.46	9.13	5.22	4.57	2.61	5.22	5.22	2.28	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	144.16	26.09	29.63	29.63	14.15	14.59	13.71	13.71	4.86	5.31
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	114.90	21.34	6.92	5.37	6.22	7.91	4.38	3.11	4.80	3.67
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	98.51	17.24	8.62	5.79	5.91	6.40	5.05	3.94	2.34	2.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	88.91	14.24	15.04	8.86	5.64	4.57	4.84	4.30	4.03	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	80.90	13.88	4.71	3.84	3.96	3.10	4.21	1.98	2.48	1.36
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	73.64	12.46	7.34	4.43	4.84	4.29	3.32	2.77	3.05	1.94
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	68.51	11.99	6.10	6.71	3.05	6.51	3.66	2.44	1.63	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	60.47	9.81	5.02	3.19	2.74	4.11	3.42	2.51	1.37	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	64.65	13.95	4.73	3.74	3.61	5.36	2.87	2.62	2.24	1.99
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	55.30	13.55	5.46	3.06	3.72	3.93	3.06	1.97	1.97	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	61.46	8.86	4.14	5.02	5.02	2.66	1.77	1.48	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	79.32	12.56	7.15	6.99	6.20	7.95	4.13	3.50	3.18	2.23
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	49.82	10.05	4.02	3.80	2.46	2.90	2.46	2.23	2.01	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	68.96	11.09	6.65	3.63	6.05	4.84	3.02	3.02	2.22	1.61
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	94.32	11.20	7.46	6.62	5.94	7.97	3.56	3.05	3.56	3.05
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	93.37	14.54	2.31	1.24	2.57	2.13	1.60	1.15	1.51	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	96.98	15.30	0.21	0.21	1.35	1.04	0.94	0.52	1.25	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	91.02	12.47	0.51	0.51	1.54	2.22	0.85	0.68	1.02	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	73.25	10.07	5.64	3.98	4.20	4.76	2.66	1.77	1.66	1.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	93.01	12.98	1.75	2.50	1.83	1.33	1.33	0.67	1.50	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	98.62	12.46	1.02	2.04	0.82	1.43	1.43	1.63	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	55.91	11.76	4.33	5.57	1.24	3.09	1.03	1.86	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	73.44	13.14	4.73	5.42	5.30	4.50	3.11	2.65	2.19	1.73
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	66.37	9.34	5.50	3.84	4.00	3.17	1.83	2.33	2.33	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	35.71	8.60	7.49	3.09	4.85	1.98	4.63	1.76	1.54	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	69.98	12.91	4.80	3.94	3.44	5.04	2.71	1.23	1.72	1.97
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	61.27	10.05	6.00	4.86	5.19	3.57	3.57	2.43	1.13	1.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	53.56	11.55	6.09	4.17	5.13	2.57	2.89	2.25	1.92	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	43.87	7.01	5.12	2.46	1.99	3.32	1.61	0.66	2.27	1.61
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	40.97	5.85	4.75	3.95	1.42	2.53	0.95	0.95	1.42	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	44.09	5.78	6.99	3.65	1.82	2.13	0.61	2.13	1.52	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	50.91	7.32	4.08	3.14	3.35	3.87	2.51	1.36	1.36	1.36
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	37.54	9.66	2.63	2.85	2.85	2.85	2.42	1.10	1.32	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	43.49	4.77	4.21	2.24	4.21	3.37	2.24	1.68	0.84	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	40.18	5.56	1.48	0.74	2.59	3.89	1.48	0.65	1.94	1.85
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	34.76	2.94	3.21	3.74	1.34	2.67	1.34	0.80	1.60	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	38.71	5.20	2.75	3.83	3.06	2.30	1.07	1.53	1.38	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	40.42	5.44	2.07	2.85	2.85	1.81	1.94	1.55	0.78	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	27.11	4.07	0.81	0.81	0.81	1.08	0.27	0.54	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	43.88	4.42	2.40	3.32	3.87	2.21	0.92	2.03	2.77	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	29.61	3.07	2.41	2.85	1.75	1.97	1.97	0.88	1.75	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	72.40	9.92	1.98	0.99	2.98	1.98	1.98	1.98	0.99	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	41.02	3.96	1.98	2.11	1.58	1.58	1.45	0.53	0.66	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	27.04	4.44	1.82	2.02	1.82	1.41	1.61	1.41	0.40	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	95.82	19.57	0.00	0.00	0.51	0.51	0.25	0.00	0.25	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	222.35	21.10	5.37	5.77	3.78	3.98	2.99	1.19	2.59	2.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	170.25	31.28	11.09	9.40	9.40	14.02	7.70	4.78	5.08	4.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	227.50	26.19	13.09	8.59	10.43	12.89	9.41	4.71	7.16	2.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	52.57	3.13	1.25	1.25	0.31	0.31	0.63	0.63	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	42.95	4.80	0.28	0.85	0.28	0.28	0.28	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	121.30	11.07	6.46	8.76	6.92	7.84	5.53	2.77	1.84	4.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	121.27	19.80	19.80	12.37	2.47	9.90	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	123.39	11.60	6.19	5.03	5.42	6.58	5.42	1.55	1.16	3.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	89.85	3.21	8.02	12.84	4.81	1.60	8.02	8.02	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	95.64	10.43	29.56	34.78	12.17	12.17	8.69	6.96	8.69	8.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	107.08	8.79	5.86	4.56	7.49	3.91	2.28	1.63	0.65	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	151.95	16.06	14.41	11.53	9.88	12.77	6.59	3.29	5.35	4.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	236.59	13.33	63.31	103.30	46.65	26.66	56.65	29.99	13.33	16.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	105.15	6.99	7.27	5.31	4.75	4.19	6.43	2.52	1.96	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	91.84	10.46	8.17	4.25	1.63	6.21	2.61	1.31	2.29	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	137.57	15.94	41.10	47.81	25.17	19.29	15.94	15.94	10.07	8.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	101.46	11.77	9.54	7.63	5.09	5.09	3.50	2.54	1.59	3.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	68.95	4.76	3.06	2.04	1.02	3.40	1.02	1.36	1.70	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	79.35	8.35	10.44	6.26	2.09	2.09	6.26	8.35	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	69.30	10.88	4.58	4.58	3.44	4.58	2.86	1.15	1.15	3.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	42.03	8.29	4.74	4.14	2.66	5.03	2.66	0.59	0.89	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	89.79	5.08	15.25	18.64	8.47	8.47	18.64	11.86	5.08	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	117.22	7.04	10.36	7.04	4.97	7.46	6.63	1.24	2.49	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	96.19	12.20	5.06	4.14	4.14	4.14	4.60	1.15	1.84	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	5.27	26.34	10.54	5.27	5.27	10.54	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	83.03	7.69	10.76	5.38	2.31	3.84	2.69	1.15	1.15	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	72.37	7.82	4.56	2.61	3.59	3.59	3.26	0.98	3.91	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	36.12	6.02	2.01	3.34	0.00	0.67	1.34	0.00	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	108.26	10.02	9.25	8.09	3.47	4.62	4.24	2.31	3.08	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	171.17	18.14	15.41	11.30	8.90	14.04	7.87	4.79	5.14	2.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	86.97	17.39	27.33	24.85	12.42	7.45	9.94	9.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	72.66	16.51	7.55	6.61	2.36	4.25	6.13	1.42	2.83	3.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	55.52	8.45	9.66	9.05	5.43	3.62	4.83	2.41	1.81	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	79.86	11.19	5.60	3.56	2.03	1.53	1.02	0.51	0.00	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	92.93	11.97	9.17	5.98	3.59	7.18	5.18	0.40	1.60	3.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	90.28	16.28	4.93	6.91	4.93	9.87	3.95	2.47	1.97	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	105.06	30.69	7.08	12.98	2.36	5.90	3.54	5.90	3.54	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	67.68	9.92	1.17	2.33	1.75	2.92	2.33	1.17	1.75	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	91.29	18.43	6.14	5.27	3.07	6.14	3.07	4.39	2.19	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	111.05	21.19	10.17	9.32	6.78	6.78	4.24	9.32	4.24	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	54.92	7.16	4.18	7.16	1.19	1.19	1.19	1.79	2.39	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	59.20	6.79	4.37	3.88	0.97	2.91	0.97	0.49	1.94	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	13.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	27.03	0.83	4.16	5.41	1.66	2.08	1.25	2.49	1.25	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	10.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	32.35	3.81	5.71	4.44	2.85	3.17	1.59	0.95	1.59	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	6.68	1.25	0.00	1.25	0.00	0.84	0.42	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	62.31	8.94	6.15	5.34	3.71	4.64	2.20	1.62	1.16	1.62
Hep-2 cells mock treated, biol_rep2	11899-125E9	77.48	10.97	6.25	5.91	3.38	4.73	2.03	1.52	2.19	1.52
Hep-2 cells mock treated, biol_rep3	11900-125F1	71.21	10.24	6.37	8.19	3.41	7.51	1.59	1.59	2.05	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	62.09	7.43	4.59	6.45	3.83	4.04	2.19	2.08	1.97	1.31
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	65.98	8.60	5.16	3.65	2.79	3.87	2.79	1.50	0.86	2.36
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	61.14	6.46	6.46	4.09	2.15	5.38	0.65	1.94	1.51	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	55.67	6.97	6.35	5.60	4.11	4.73	3.24	2.12	1.25	1.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	61.59	6.00	4.12	2.23	4.12	2.57	2.23	1.37	1.72	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	58.95	8.65	4.49	3.84	3.84	3.84	2.24	2.56	1.28	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.72	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	4.33	1.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	2.64	2.64	2.64	0.00	0.00	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	7.05	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	10.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	17.66	2.10	1.05	1.57	0.87	0.52	0.35	0.52	0.35	0.87
Hepatocyte, donor1	11523-119I2	88.37	13.32	10.90	4.84	3.63	7.26	9.68	2.42	7.26	3.63
Hepatocyte, donor2	11603-120I1	75.41	17.24	2.15	2.15	6.46	3.23	10.77	3.23	0.00	2.15
Hepatocyte, donor3	11684-122I1	69.94	14.72	10.43	6.75	13.50	14.11	11.04	4.29	4.29	6.14
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	295.01	31.33	9.14	12.40	8.48	7.83	7.83	4.57	4.57	7.83
Intestinal epithelial cells (polarized), donor1	11246-116E4	132.13	15.91	4.02	2.62	1.57	2.45	1.75	2.27	1.57	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	28.26	3.84	1.92	1.10	0.82	1.23	1.23	0.55	0.55	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	9.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	11.08	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	10.01	0.00	0.00	0.00	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	33.32	25.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	9.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	24.36	21.12	1.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	21.67	8.34	0.00	3.33	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	26.47	10.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	17.74	4.43	0.00	0.00	1.11	2.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	10.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	15.75	5.04	0.00	0.00	1.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	18.56	7.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	14.21	6.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	19.32	12.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	35.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	24.45	10.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	17.21	1.26	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	28.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	17.68	9.64	0.00	0.00	0.00	0.00	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.93	3.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.50	6.14	0.94	0.00	0.47	0.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	11.79	2.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	15.07	10.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	15.25	5.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	18.49	8.29	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	10.94	3.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	16.42	5.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	6.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	18.21	3.40	0.31	0.00	0.31	0.31	0.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	15.80	7.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	9.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	28.51	9.74	0.00	0.00	0.70	0.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	6.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	3.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	15.69	8.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	15.75	20.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	20.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	12.80	9.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	23.55	11.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	16.57	3.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	9.08	0.00	3.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	18.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	15.86	7.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	25.95	6.77	0.73	0.49	0.41	0.24	0.73	0.16	0.33	0.41
Keratinocyte - epidermal, donor2	11349-117G8	5.27	3.51	0.00	0.59	0.00	0.59	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	41.08	12.31	8.33	5.68	5.11	4.92	3.12	2.46	1.80	2.56
Keratinocyte - oral, donor1	11251-116E9	48.02	14.53	1.82	1.59	0.91	1.14	0.45	0.57	0.57	0.34
Keratocytes, donor1	11527-119I6	12.03	5.50	0.00	0.00	0.00	0.69	0.34	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	9.37	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	13.04	3.95	1.19	1.98	1.78	1.38	1.38	0.40	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	112.09	26.37	4.40	0.00	0.00	2.20	2.20	0.00	4.40	0.00
Lens Epithelial Cells, donor1	11529-119I8	32.36	0.00	7.55	5.39	1.08	3.24	1.08	1.08	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	40.48	4.96	1.15	1.04	1.27	0.81	1.04	0.46	0.12	0.35
Lens Epithelial Cells, donor3	11690-122I7	21.19	3.43	0.30	0.00	0.10	0.10	0.10	0.10	0.20	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	13.64	3.32	0.47	0.00	0.12	0.36	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.81	1.95	1.12	1.12	0.28	0.56	1.12	0.28	0.84	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	24.24	5.98	5.04	4.09	2.99	3.62	2.83	1.73	1.89	1.89
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	12.91	3.23	1.08	1.08	0.54	0.54	1.08	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	6.30	1.26	0.32	0.32	0.32	0.63	0.63	0.00	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.36	1.40	1.08	1.08	0.65	0.86	0.43	0.22	0.32	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	18.06	6.16	0.82	2.46	1.23	0.82	1.64	0.41	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.56	3.29	0.00	0.76	0.25	0.00	0.25	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	10.13	2.25	2.11	2.39	1.83	1.27	0.84	0.84	0.56	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	15.43	3.96	1.19	0.79	0.79	2.37	0.40	0.00	0.79	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	11.05	5.23	3.10	2.91	0.58	1.36	1.36	1.55	0.00	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.96	1.30	0.37	0.00	0.56	0.37	0.00	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	10.80	3.14	0.70	1.05	1.05	2.09	1.05	0.00	0.35	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	12.16	1.67	1.19	0.00	0.95	0.24	1.43	0.24	0.24	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	8.24	1.65	1.65	0.96	0.27	0.96	1.37	0.55	0.14	0.96
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	22.79	4.00	1.85	2.16	1.85	1.23	0.62	0.62	0.92	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.42	3.12	1.56	0.31	0.31	0.31	0.94	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.08	2.74	0.91	1.28	0.91	0.91	0.91	0.37	0.37	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	12.51	5.59	1.32	1.65	0.99	2.63	0.99	0.99	0.99	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.15	2.93	0.29	0.59	0.88	0.59	0.29	0.00	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.48	1.00	0.75	0.25	0.00	0.25	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	21.34	3.88	1.94	2.42	2.42	3.39	2.91	1.45	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	12.66	4.58	1.08	1.08	1.08	1.35	0.54	0.54	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.20	3.03	0.61	1.51	0.61	0.45	0.76	0.45	0.91	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	13.48	2.07	1.04	1.56	1.56	0.00	0.00	0.00	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	18.85	5.86	3.14	5.03	1.47	1.88	1.05	0.84	0.84	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.82	1.50	0.75	1.35	0.45	1.05	0.45	0.00	0.30	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	17.20	2.06	0.69	2.75	0.00	1.38	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	11.67	2.63	0.56	2.07	1.13	0.75	0.38	0.19	0.56	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	6.57	1.06	0.42	0.64	0.32	0.53	0.32	0.11	0.21	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	14.05	2.91	2.42	3.39	2.91	3.39	2.42	1.94	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	6.95	2.65	0.66	0.66	0.33	0.33	0.33	1.65	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	5.33	1.61	1.12	0.50	0.87	0.99	0.25	0.12	0.37	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	27.77	7.03	2.22	1.48	2.22	3.70	1.11	1.48	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	12.60	3.95	0.49	0.99	0.99	0.49	0.74	0.25	0.49	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.36	1.51	0.14	0.55	0.14	0.41	0.82	0.00	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	20.58	5.47	1.93	2.25	0.96	1.61	0.32	0.00	0.96	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	27.39	4.87	3.04	1.83	1.52	2.43	0.30	0.61	2.13	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	13.58	3.22	1.68	2.52	2.10	2.10	0.70	0.70	0.56	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	16.00	4.27	0.71	2.13	1.42	0.71	0.36	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.30	1.94	1.94	0.00	0.00	0.48	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.73	2.02	0.16	0.16	0.16	0.16	0.31	0.16	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	10.74	2.15	3.22	1.07	1.79	1.07	0.36	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	10.45	2.29	0.65	0.33	0.65	0.33	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	5.18	0.24	0.47	0.24	0.00	0.00	0.00	0.00	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	12.99	1.98	0.25	0.37	0.25	0.25	0.62	0.00	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3.84	2.31	0.26	0.26	0.00	1.02	0.00	0.00	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	9.55	1.49	0.60	0.60	0.90	0.60	0.60	0.30	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	38.52	6.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	32.22	0.77	0.77	0.77	1.53	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	24.49	2.97	0.74	0.00	0.00	0.00	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	36.81	2.12	1.69	1.27	1.27	0.85	0.42	0.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	40.09	1.41	2.11	0.00	0.70	0.00	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	30.82	2.80	0.00	0.00	0.93	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	33.49	3.61	1.55	0.52	0.00	0.00	0.52	1.03	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	15.46	7.14	0.00	0.00	2.38	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	38.45	2.26	0.00	0.45	0.00	0.00	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	47.40	3.49	1.16	1.45	2.62	2.62	2.33	0.87	1.45	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	59.87	3.15	5.85	2.25	0.45	1.80	1.80	1.80	1.80	2.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	38.34	2.30	0.27	0.27	0.27	0.14	0.27	0.27	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	31.32	3.08	0.51	0.00	0.00	1.03	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	51.52	5.65	0.71	0.71	1.41	1.06	1.76	0.35	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	44.64	3.33	0.00	0.67	2.67	0.67	2.00	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	45.84	2.04	1.02	3.06	0.00	1.02	0.00	2.55	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	62.17	5.60	3.20	2.93	2.40	1.60	1.07	1.33	0.27	1.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	63.49	5.10	3.40	3.21	2.46	1.51	2.08	1.13	0.76	1.51
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	41.11	3.68	1.84	2.45	0.61	0.61	1.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	41.59	2.45	2.45	2.45	0.82	0.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	58.93	4.37	3.96	4.37	1.87	2.50	1.25	2.08	1.67	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	49.89	4.76	3.08	5.04	2.52	1.68	2.24	2.80	0.84	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	47.40	1.03	0.00	1.03	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	59.22	3.48	3.19	5.23	2.61	3.48	0.87	1.45	0.87	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	37.07	2.69	2.09	3.29	1.20	0.60	0.60	1.49	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	44.26	2.77	4.43	1.66	1.11	2.21	2.77	0.55	1.66	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	44.89	3.89	2.47	1.06	1.06	2.47	0.35	0.71	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	42.78	4.43	1.11	2.21	0.74	0.00	0.00	0.74	1.11	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	35.69	3.45	2.30	0.00	0.00	0.00	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	37.99	1.54	1.54	1.92	0.38	0.77	1.15	1.15	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	35.10	4.53	1.70	1.70	0.57	0.57	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	37.74	0.82	0.00	0.82	0.00	1.64	1.64	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	33.44	2.26	2.71	0.45	0.45	1.36	0.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	29.44	2.15	1.44	0.72	0.00	1.44	0.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	45.56	5.23	2.24	0.75	0.75	0.00	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	34.19	2.60	2.23	0.74	1.49	2.23	2.60	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	36.18	4.31	1.29	0.86	0.43	0.00	0.86	0.00	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	27.40	4.28	0.00	1.71	0.86	1.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	32.32	2.00	1.67	2.00	1.00	0.33	1.00	1.67	0.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	21.12	3.62	1.21	0.60	0.00	1.21	1.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	26.31	4.27	0.00	0.00	0.71	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	31.28	2.75	1.37	1.03	0.34	1.03	2.06	0.69	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	28.45	4.29	1.07	2.68	0.00	0.54	1.07	0.54	1.07	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	21.55	2.02	0.00	0.67	0.67	0.00	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	32.97	2.96	2.96	1.11	1.85	1.48	2.22	1.48	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	31.40	1.16	0.00	0.00	0.00	0.00	0.00	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	33.85	4.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	42.82	3.20	0.80	0.80	2.00	0.40	0.40	0.40	1.60	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	34.89	4.36	2.18	0.73	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	58.26	5.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	39.96	4.93	1.97	0.99	0.49	0.49	0.99	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	31.99	5.65	0.00	0.00	0.00	0.00	1.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	38.72	5.03	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	41.01	2.70	2.70	0.00	0.45	1.80	1.35	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	65.40	1.72	0.00	3.44	1.72	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	41.42	5.79	4.01	0.89	0.89	1.34	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	49.27	6.26	1.56	0.39	0.00	0.39	1.56	0.78	0.39	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	44.86	1.98	3.30	0.00	0.66	1.32	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	47.74	1.56	1.04	0.52	0.52	0.52	1.04	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	54.26	6.13	1.31	1.31	0.00	0.00	1.75	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	45.29	7.27	1.12	2.24	0.00	1.12	1.68	0.00	1.68	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	52.11	4.86	0.88	0.44	0.00	0.00	0.88	0.88	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	54.77	3.09	1.16	0.77	0.39	0.00	0.39	1.54	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	47.09	4.05	4.05	1.01	0.51	0.51	0.51	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	47.10	2.88	1.44	2.40	2.40	0.48	0.96	0.48	0.48	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	41.34	4.77	1.59	0.80	2.39	1.19	0.80	0.80	0.80	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	38.89	6.08	0.61	1.22	1.22	1.22	1.22	0.00	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	42.19	6.23	1.38	0.00	0.69	1.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	44.08	3.04	1.14	1.90	0.00	1.52	0.76	0.00	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	44.93	5.16	1.03	0.52	1.03	0.52	1.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	32.05	4.23	0.60	1.21	0.60	0.60	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	43.10	2.22	1.58	2.85	1.27	2.54	1.27	0.00	0.63	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	41.58	5.33	0.53	0.00	0.00	0.00	1.60	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	41.38	2.87	0.00	0.57	0.00	0.00	0.00	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	48.34	3.60	2.06	1.54	0.00	3.60	0.51	0.00	0.00	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	31.83	4.95	0.00	0.71	0.71	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	32.91	4.54	1.13	0.57	0.57	0.57	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	38.69	6.66	1.25	2.50	0.42	0.83	0.42	0.00	0.42	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	32.10	6.26	3.13	0.00	0.00	0.00	0.78	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	37.58	3.76	1.25	1.25	0.00	1.25	0.42	0.42	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	32.06	4.65	1.39	1.39	0.00	0.00	0.00	0.46	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	34.12	5.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	29.41	4.28	0.00	2.14	0.53	0.00	1.07	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	42.83	1.62	1.21	1.62	0.00	0.00	1.21	0.40	0.00	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	36.71	3.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	35.56	0.89	2.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	30.77	5.13	1.71	0.57	0.00	0.57	0.57	0.00	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	24.54	1.53	0.77	0.00	0.00	0.00	0.00	0.00	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	33.38	1.64	1.09	1.09	1.09	0.00	1.64	0.00	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	37.42	4.90	0.89	0.89	0.45	0.45	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	36.91	3.38	1.04	0.26	0.26	0.00	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	39.12	4.64	1.99	0.00	0.66	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	2.08	0.00	2.08	0.00	0.00	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	35.10	7.29	0.46	0.91	0.46	0.23	0.23	0.23	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	21.65	5.32	0.37	1.28	0.18	0.37	0.73	0.18	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	30.28	5.77	0.52	0.39	0.66	1.05	0.39	0.66	0.66	0.92
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	15.40	2.66	0.00	1.06	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	47.85	5.86	2.54	1.43	0.48	1.43	0.95	0.79	0.48	0.16
Mallassez-derived cells, donor3	11930-125I4	51.15	6.95	1.67	1.53	1.11	0.83	0.83	0.83	0.28	0.14
Mammary Epithelial Cell, donor1	11273-116H4	38.96	11.66	3.49	1.79	2.09	2.19	1.89	1.10	1.20	1.10
Mammary Epithelial Cell, donor2	11350-117G9	39.67	10.42	4.34	4.63	2.61	2.90	1.16	1.16	0.87	0.87
Mammary Epithelial Cell, donor3	11422-118F9	6.98	1.25	0.25	0.50	0.00	0.25	0.50	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	1023.01	168.13	2.03	0.68	8.14	21.02	6.10	0.68	12.88	2.03
Mast cell, donor1	11563-120D6	84.46	16.98	2.70	1.30	1.62	2.60	2.49	1.30	1.30	0.97
Mast cell, donor2	11565-120D8	134.62	30.01	1.19	1.78	0.59	1.49	1.49	0.89	2.38	1.19
Mast cell, donor3	11566-120D9	167.72	43.90	1.58	0.68	0.90	2.25	0.90	0.90	0.90	0.23
Mast cell, donor4	11567-120E1	98.75	29.25	0.35	0.35	0.18	0.53	0.53	0.18	0.71	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	107.12	16.19	5.43	2.77	3.99	2.33	2.88	2.55	2.55	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	70.04	9.92	1.75	1.75	0.00	1.75	1.75	0.58	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	88.22	13.31	1.84	3.21	1.15	0.92	1.38	0.57	0.57	0.23
Mast cell, expanded, donor8	11941-126A6	102.60	16.40	2.85	2.51	1.00	0.67	1.17	0.67	1.17	0.67
Melanocyte - dark, donor1	11502-119F8	27.66	4.08	0.60	0.70	0.20	0.40	0.10	0.50	0.20	0.10
Melanocyte - dark, donor2	11582-120F7	15.23	1.73	0.35	1.73	1.73	1.04	0.00	0.00	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	56.14	7.24	2.54	1.59	1.74	1.16	0.80	0.72	0.72	0.07
Melanocyte - light, donor1	11274-116H5	6.58	0.71	0.47	0.00	0.00	0.00	0.24	0.00	0.00	0.24
Melanocyte - light, donor2	11351-117H1	6.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.94	0.87	0.00	0.87	1.73	0.87	0.87	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	42.17	8.54	2.60	2.19	1.56	2.29	0.31	0.94	1.25	1.25
Melanocyte, donor2 (MC+2)	12739-135I3	20.44	2.96	2.15	1.61	0.81	1.88	1.34	0.81	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	35.36	6.16	1.34	1.87	0.27	0.80	0.54	0.27	0.54	0.54
Meningeal Cells, donor1	11493-119E8	27.29	3.10	0.25	0.25	0.12	0.25	0.00	0.00	0.00	0.00
Meningeal Cells, donor2	11573-120E7	24.21	1.32	0.00	0.00	0.00	0.00	0.00	0.44	0.00	0.44
Meningeal Cells, donor3	11654-122E7	56.40	7.91	1.55	1.47	1.22	0.98	0.73	0.33	0.41	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	25.09	4.28	0.00	0.57	0.86	0.00	0.29	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	38.44	8.96	0.70	0.60	0.40	0.30	0.40	0.60	0.40	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	22.96	6.46	3.59	2.87	2.15	2.15	1.44	0.00	1.44	3.59
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	31.98	2.96	0.85	0.42	0.64	1.06	0.64	1.06	0.42	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	30.16	4.52	3.02	3.02	1.01	3.02	1.51	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	12.53	2.86	0.00	0.22	0.22	0.22	0.88	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	1.46	1.46	0.00	0.00	0.00	0.00	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	10.64	2.25	0.20	0.20	0.61	0.20	0.20	0.20	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	23.82	4.29	1.25	1.94	0.97	0.55	0.28	0.28	0.14	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	8.18	1.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	31.58	4.47	1.84	1.71	0.79	0.92	0.79	1.18	0.53	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.90	2.97	0.30	0.00	0.00	0.30	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00	0.00	0.00	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	10.89	3.84	0.64	0.64	0.64	0.64	0.00	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	38.28	7.09	0.71	1.42	0.00	0.71	0.00	0.00	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	23.14	4.38	0.00	1.25	0.00	0.31	0.31	0.00	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	18.14	9.43	0.73	1.45	0.73	0.73	0.00	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	32.62	6.63	0.80	1.06	0.00	0.53	0.80	0.27	1.06	0.00
Mesothelial Cells, donor2	12156-128G5	20.02	1.50	0.50	0.00	0.00	0.50	0.00	1.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	29.92	3.47	5.28	3.90	3.54	3.83	3.90	3.47	2.17	1.37
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	47.26	1.35	0.00	0.00	0.00	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	32.26	5.17	0.99	0.25	0.00	1.23	1.72	0.49	0.25	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	24.73	5.59	1.18	2.06	0.88	0.88	0.59	0.59	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	3.46	0.00	0.00	0.00	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	19.22	2.48	1.24	0.31	0.00	0.31	0.31	0.31	0.62	1.55
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	18.05	3.53	2.49	2.49	2.90	0.41	1.24	1.45	0.83	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	4.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	17.27	3.25	1.00	0.50	0.50	0.00	0.75	0.25	0.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	22.81	2.79	0.00	0.93	0.00	0.93	0.93	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	15.85	2.44	1.02	0.81	0.41	0.00	0.41	0.00	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	16.23	5.15	0.40	1.19	0.00	0.79	0.40	0.79	0.79	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	1.77	0.88	0.88	0.00	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	18.24	3.42	1.90	3.42	0.00	1.52	0.38	1.14	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	18.42	0.00	0.00	0.00	1.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	12.31	4.46	1.27	0.64	1.27	1.27	0.21	0.85	0.64	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	8.29	0.92	0.00	0.00	0.00	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	13.71	2.38	0.60	0.60	0.30	0.30	0.60	0.00	0.30	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	1.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	15.05	3.01	1.25	0.50	0.75	0.50	0.00	0.50	0.50	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	14.50	4.04	1.19	1.19	1.19	0.71	2.38	0.48	0.71	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	14.37	2.21	0.00	0.00	0.00	0.00	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	12.20	1.15	0.92	0.00	0.46	0.69	0.46	0.23	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	11.15	3.16	0.63	1.05	0.42	0.42	0.42	0.42	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.78	1.63	0.61	0.00	0.61	0.00	0.20	0.20	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	16.95	2.15	0.64	0.43	0.00	0.43	0.00	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	16.00	3.33	0.00	0.22	0.67	0.67	0.22	0.00	0.67	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	11.17	1.10	1.10	0.22	0.44	0.00	0.66	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	13.18	1.01	0.51	0.00	0.00	0.00	0.00	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	3.31	0.00	0.00	0.00	0.00	0.00	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	13.32	2.17	0.82	0.27	0.27	0.54	1.09	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	9.41	2.35	0.29	0.29	0.00	0.59	0.00	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	1.09	0.00	1.09	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	7.69	2.40	0.48	0.00	0.00	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	9.61	2.80	0.40	1.20	0.40	1.20	0.80	0.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	10.97	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	7.01	1.00	2.00	0.00	0.00	0.00	0.00	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	10.95	0.88	0.44	0.00	0.88	0.00	0.00	0.88	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	12.14	5.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.25	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	15.12	2.48	0.99	0.99	0.74	0.50	0.25	0.50	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	20.18	6.96	0.70	0.70	0.00	0.00	0.70	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	6.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	13.68	2.39	0.68	1.03	1.37	0.68	0.00	0.34	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	20.57	5.25	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	20.60	2.84	0.00	0.00	0.00	0.00	0.71	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	14.59	2.24	0.28	0.56	0.84	0.28	0.28	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	16.21	3.33	0.00	0.00	0.00	0.83	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	18.07	2.91	0.00	0.00	0.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	12.67	2.11	1.81	0.60	1.21	1.21	0.30	0.30	0.90	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	20.45	2.92	0.42	0.00	0.00	1.67	0.42	0.83	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	16.62	3.69	0.00	0.00	0.00	0.92	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	20.49	4.55	0.00	0.57	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	20.59	3.32	0.55	0.14	0.28	0.14	0.00	0.14	0.28	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	11.66	1.55	1.04	0.52	0.00	0.78	0.78	0.26	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	20.16	3.00	0.43	0.00	0.43	0.00	0.86	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	14.61	1.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	21.35	2.67	1.33	0.80	0.53	0.27	0.80	0.00	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	17.06	6.29	1.50	0.60	0.30	0.60	0.30	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	17.80	2.68	0.71	0.14	0.14	0.14	0.57	0.14	0.00	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.97	2.55	0.00	0.64	0.32	0.64	0.00	0.32	0.96	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	21.01	3.76	0.00	0.44	1.11	0.88	0.44	0.44	0.22	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	17.44	4.17	0.00	0.00	0.00	0.38	0.00	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	21.59	2.84	0.57	0.85	1.14	0.00	0.57	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	15.98	3.20	1.23	0.74	0.49	1.47	0.25	0.00	0.74	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.69	4.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	18.82	3.53	0.00	0.88	0.59	0.29	0.59	0.88	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	22.78	3.17	2.02	0.86	0.29	0.86	0.58	0.29	0.29	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	28.85	3.30	1.24	0.82	0.41	0.41	0.41	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.16	2.98	0.30	0.60	0.60	1.19	0.30	0.30	0.89	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	1.78	1.78	1.78	0.00	0.00	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	14.79	2.63	2.30	1.97	0.66	0.66	1.97	1.64	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	7.36	0.00	1.05	2.10	0.00	2.10	2.10	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	20.36	1.58	0.40	0.99	0.20	0.00	0.20	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	17.70	2.79	0.00	0.00	1.86	0.00	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	13.89	2.25	1.88	1.88	1.13	0.38	1.88	1.13	0.75	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	12.52	3.73	0.27	0.00	0.27	0.27	0.53	0.27	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	24.32	3.28	0.00	0.00	0.23	0.00	0.11	0.11	0.23	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.89	0.74	2.95	3.68	0.74	0.00	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	15.76	4.76	3.30	1.47	1.83	1.47	1.10	0.73	0.37	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	15.56	6.22	15.56	3.11	9.33	7.78	3.11	3.11	9.33	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.77	4.81	0.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	3.03	0.00	4.04	1.01	0.00	0.00	1.01	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	11.81	2.53	1.69	0.84	0.42	0.84	2.11	0.42	0.42	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	43.58	12.26	1.36	0.00	0.00	0.00	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	3.81	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	1.62	1.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	24.17	13.59	1.51	3.02	0.00	1.51	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	211.28	114.20	0.00	0.00	0.00	0.00	0.00	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	182.70	123.97	3.26	0.00	0.00	6.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	33.27	0.00	0.00	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	125.49	175.69	0.00	0.00	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	31.02	4.09	1.94	0.86	1.29	0.22	0.43	0.86	0.43	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	39.72	1.05	6.27	0.52	3.14	0.52	1.05	1.05	2.61	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	18.69	6.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.02	3.34	0.83	0.00	0.00	0.00	0.00	0.00	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	53.05	9.32	1.33	0.57	0.76	0.76	0.38	0.00	0.38	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	87.77	12.77	1.60	0.00	1.60	1.60	7.98	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	5.44	3.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	200.30	27.56	11.03	11.03	1.84	5.51	7.35	0.00	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	11.72	1.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	13.48	4.65	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.08	2.97	0.00	0.00	0.27	0.27	0.00	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	33.01	6.10	1.89	1.05	0.63	0.63	1.89	0.21	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1180.28	122.48	11.13	0.00	11.13	55.67	11.13	11.13	55.67	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	10.92	3.47	1.49	0.00	0.50	0.50	0.50	0.99	0.00	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	19.76	3.79	0.54	0.81	0.54	0.00	0.27	0.00	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.29	1.59	0.23	0.23	0.23	0.45	0.00	0.00	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	10.12	2.78	0.00	0.00	0.16	0.16	0.16	0.00	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	34.63	4.01	1.09	0.91	0.18	1.46	0.36	0.55	0.55	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	16.44	2.65	0.53	0.00	0.00	0.00	0.53	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	10.81	3.00	0.00	0.00	0.60	0.00	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	56.12	7.22	1.31	0.98	1.97	0.98	1.97	0.33	0.00	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.62	2.76	0.16	0.16	0.00	0.00	0.16	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	50.80	5.64	1.76	1.06	1.94	0.53	1.94	0.35	0.18	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.74	2.81	0.00	0.00	0.00	0.00	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	7.82	2.76	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.96	1.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	48.28	7.59	0.69	1.38	1.03	0.34	1.72	0.69	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	346.40	22.76	7.59	7.59	5.06	5.06	2.53	0.00	5.06	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	36.31	5.79	0.89	0.22	0.67	0.67	1.34	0.45	0.45	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.13	2.54	0.00	0.42	0.00	0.00	0.42	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	16.85	3.80	0.24	0.24	0.47	0.71	0.47	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	10.30	2.58	0.43	0.43	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1507.64	135.42	27.08	18.06	27.08	27.08	9.03	9.03	0.00	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	13.33	1.00	0.33	0.33	0.00	0.00	0.33	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.54	2.71	0.45	0.00	0.45	0.00	0.45	0.00	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	10.32	2.78	0.00	0.00	1.19	0.00	0.40	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.93	3.71	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	15.51	6.81	0.38	0.00	0.00	0.38	0.76	0.00	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	8.80	1.63	0.33	0.33	0.00	0.33	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	13.95	3.05	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	49.75	4.07	0.45	1.36	0.45	0.45	0.90	0.90	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.94	3.53	0.00	0.88	0.00	0.00	0.00	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	11.97	1.33	1.33	0.66	0.66	0.66	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	14.88	2.98	1.49	0.50	0.50	0.00	0.50	0.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.93	3.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	31.45	5.75	0.91	0.91	0.30	0.91	0.60	0.30	0.60	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	36.25	3.54	2.43	1.99	0.88	1.33	0.88	0.22	0.66	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	7.45	5.42	1.36	1.36	0.00	0.00	0.00	0.68	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	352.56	35.77	20.44	5.11	0.00	5.11	0.00	5.11	10.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.32	1.83	0.61	0.61	0.00	0.61	0.00	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.96	1.57	0.00	0.00	0.00	0.31	0.63	0.31	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	11.50	2.42	0.30	0.00	0.30	0.00	0.30	0.30	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.87	3.16	0.00	1.58	0.00	0.00	1.58	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	58.95	12.47	2.27	1.13	0.00	2.27	0.00	1.13	2.27	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	354.05	15.17	25.29	5.06	10.12	5.06	15.17	10.12	5.06	25.29
Myoblast, donor1	11241-116D8	36.52	6.71	1.37	1.86	0.50	0.62	0.25	0.25	0.50	0.37
Myoblast, donor2	11322-117D8	40.47	6.90	3.26	3.07	1.92	2.88	1.15	0.96	0.96	0.58
Myoblast, donor3	11398-118D3	48.09	6.73	1.18	0.84	0.00	0.67	0.50	0.00	0.67	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	102.01	21.45	15.03	10.94	9.05	9.05	7.59	5.69	3.36	2.92
Natural Killer Cells, donor1	11230-116C6	213.11	37.52	8.00	5.23	7.07	4.00	5.23	3.08	5.84	3.08
Natural Killer Cells, donor2	11311-117C6	162.24	25.33	13.87	20.81	12.06	17.79	8.14	9.65	6.94	6.33
Natural Killer Cells, donor3	11387-118C1	182.40	30.92	17.85	17.12	13.44	15.64	6.81	8.47	8.47	7.55
Neural stem cells, donor1	11275-116H6	204.34	13.07	2.54	3.27	1.81	4.72	4.36	2.54	2.90	0.73
Neural stem cells, donor2	11352-117H2	233.00	32.74	0.00	0.00	0.00	3.85	0.00	1.93	3.85	0.00
Neurons, donor1	11494-119E9	94.45	13.65	5.69	10.24	1.14	2.28	3.41	3.41	0.00	3.41
Neurons, donor2	11574-120E8	56.58	8.59	3.74	1.76	0.88	1.32	1.10	0.66	1.76	0.22
Neurons, donor3	11655-122E8	69.88	15.62	3.29	3.29	4.93	2.47	4.11	1.64	1.64	4.11
Neutrophils, donor1	11233-116C9	82.59	32.48	17.63	8.35	3.71	3.71	1.86	5.57	2.78	2.78
Neutrophils, donor2	11314-117C9	75.37	26.09	5.80	14.49	14.49	11.60	0.00	0.00	8.70	11.60
Neutrophils, donor3	11390-118C4	95.29	36.04	3.05	1.22	1.22	1.83	1.83	1.83	2.44	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	23.87	4.63	1.42	0.95	0.24	0.71	0.00	0.36	0.47	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	7.81	1.30	0.65	1.95	0.00	0.00	0.65	0.65	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	12.43	2.41	0.20	1.40	0.20	0.80	0.40	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	21.75	2.48	3.85	2.20	1.51	1.65	0.83	1.38	0.28	0.55
Olfactory epithelial cells, donor2	11934-125I8	27.65	4.49	5.07	5.79	2.61	2.32	1.59	2.46	0.29	1.45
Olfactory epithelial cells, donor3	11935-125I9	22.13	4.20	3.06	2.72	2.27	1.48	1.82	0.91	0.34	0.91
Olfactory epithelial cells, donor4	11936-126A1	26.49	3.80	2.82	1.95	1.07	1.56	1.46	0.97	0.88	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	34.30	7.22	2.41	0.60	1.20	0.60	0.60	0.60	0.60	1.20
Osteoblast - differentiated, donor1	11276-116H7	8.93	1.70	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.43
Osteoblast - differentiated, donor2	11353-117H3	4.57	2.29	0.00	0.00	0.00	1.14	0.00	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	8.69	0.00	0.00	0.00	1.24	0.00	1.24	0.00	0.62	1.24
Osteoblast, donor1	11277-116H8	7.04	1.76	0.20	0.20	0.00	0.20	0.00	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	49.86	4.92	2.11	0.70	4.21	2.81	1.40	2.11	0.70	0.70
Osteoblast, donor3	11426-118G4	16.53	2.84	0.36	0.18	0.18	0.18	0.18	0.18	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	42.20	4.97	1.68	1.68	0.76	0.93	0.67	0.67	0.67	0.08
Pericytes, donor1	11491-119E6	6.12	0.22	0.00	0.22	0.00	0.00	0.11	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	4.98	1.13	0.23	0.00	0.00	0.00	0.23	0.23	0.00	0.23
Pericytes, donor3	11652-122E5	4.68	2.03	0.41	0.00	0.00	0.20	0.41	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	43.97	6.67	1.58	1.24	0.34	1.13	0.79	0.68	0.23	0.34
Perineurial Cells, donor2	11579-120F4	22.82	2.30	0.37	0.37	0.18	0.18	0.28	0.09	0.18	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	245.75	44.30	5.42	3.82	4.46	5.74	1.59	2.23	2.55	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	123.41	25.96	4.65	5.14	3.67	1.47	1.47	1.22	1.22	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	136.27	21.74	4.27	3.62	1.81	1.81	0.52	1.81	0.78	1.42
Placental Epithelial Cells, donor1	11278-116H9	13.39	2.63	0.72	0.00	0.00	0.00	0.24	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	14.42	0.00	0.00	0.00	0.00	1.11	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	13.15	1.37	0.39	0.39	0.20	0.00	0.39	0.20	0.00	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.01	2.22	0.00	0.63	0.32	0.00	0.32	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	24.01	2.44	0.19	0.19	0.56	0.19	1.13	0.19	0.38	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	97.90	10.31	1.57	1.96	2.09	1.44	1.17	1.96	1.17	0.78
Preadipocyte - breast, donor2	11328-117E5	26.12	3.15	1.80	1.58	1.80	1.80	0.00	1.13	0.45	0.45
Preadipocyte - omental, donor1	11468-119C1	29.52	2.98	0.53	0.11	0.53	0.64	0.85	0.32	0.64	0.11
Preadipocyte - omental, donor2	11329-117E6	28.81	4.36	0.44	0.44	0.87	1.75	1.31	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	30.66	4.01	3.87	1.43	2.15	1.72	1.58	1.72	1.15	0.86
Preadipocyte - perirenal, donor1	11469-119C2	6.89	1.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	12.90	1.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	62.15	6.02	5.84	5.31	4.96	4.43	3.36	2.66	3.01	3.01
Preadipocyte - subcutaneous, donor3	11428-118G6	28.61	3.07	1.53	1.19	0.85	1.36	0.85	0.51	1.53	0.51
Preadipocyte - visceral, donor1	11280-116I2	63.53	8.29	2.24	1.21	1.68	1.02	1.40	0.75	0.84	0.93
Preadipocyte - visceral, donor2	11357-117H7	29.45	5.52	3.22	0.00	0.92	2.76	0.46	0.46	0.46	1.38
Preadipocyte - visceral, donor3	11429-118G7	33.44	3.55	2.09	1.67	1.57	1.15	1.25	0.94	0.21	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	105.45	16.44	7.69	4.07	2.41	2.26	2.41	1.06	1.51	1.36
Prostate Epithelial Cells, donor2	11331-117E8	22.61	6.09	1.35	1.08	0.81	0.95	0.95	0.41	0.00	0.27
Prostate Epithelial Cells, donor3	11404-118D9	25.05	18.55	7.65	4.78	3.61	3.61	3.31	2.88	1.59	1.29
Prostate Stromal Cells, donor1	11254-116F3	35.42	6.04	0.91	1.82	0.91	0.46	0.46	0.57	0.00	0.46
Prostate Stromal Cells, donor2	11332-117E9	41.78	5.92	7.17	6.99	4.48	4.66	3.59	4.48	3.05	2.69
Prostate Stromal Cells, donor3	11405-118E1	27.74	3.34	2.71	1.36	1.36	2.19	0.94	0.42	0.73	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.76	2.19	0.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	28.83	4.78	1.87	1.52	1.25	0.90	0.76	0.49	0.21	0.14
Renal Epithelial Cells, donor1	11517-119H5	10.65	3.04	0.00	0.00	0.00	0.51	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	9.25	1.42	0.00	0.00	1.42	0.00	0.00	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	33.98	6.25	3.07	2.12	0.64	1.16	1.48	0.42	0.42	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	6.13	2.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.89	2.29	0.00	0.54	0.00	0.13	0.00	0.27	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	36.41	4.00	3.33	4.00	2.44	2.44	2.44	0.89	1.78	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.99	2.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	7.04	2.20	0.00	0.44	0.22	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	7.52	3.13	1.25	0.63	0.00	0.63	0.00	1.25	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	3.88	0.83	0.55	0.55	0.00	0.00	0.00	0.00	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	15.57	4.56	1.07	0.27	0.00	0.00	0.00	0.00	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	7.17	2.53	0.42	0.00	0.84	0.42	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	9.45	1.54	1.16	0.19	0.19	0.00	0.39	0.19	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	49.00	6.74	1.30	1.04	1.30	1.30	1.04	0.78	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	16.77	2.27	1.71	0.28	1.14	0.28	0.28	0.28	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	1.03	1.03	0.00	0.00	0.00	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	36.38	5.27	1.00	0.25	0.00	0.25	0.75	0.75	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	99.16	24.99	3.47	2.14	3.07	1.60	1.34	0.27	0.67	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	151.88	20.55	4.47	3.57	1.79	5.36	3.57	0.89	2.68	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	499.19	36.87	94.11	30.82	35.22	29.17	39.08	15.41	12.11	17.61
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	748.27	53.37	30.16	7.54	14.50	5.22	14.50	2.90	6.38	8.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	267.20	18.59	5.72	4.42	3.51	4.29	2.99	2.08	2.86	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	144.39	15.09	21.35	11.62	11.12	10.82	8.34	5.46	6.75	4.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	212.71	20.86	6.25	5.47	4.24	3.79	4.02	2.01	1.23	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	279.72	26.05	27.79	23.82	13.40	20.59	11.29	7.57	8.06	8.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	163.51	16.08	21.09	15.27	10.61	11.89	10.96	7.58	6.18	5.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	215.41	21.73	35.83	15.02	27.50	23.58	20.57	8.55	11.79	15.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	182.50	17.25	13.14	11.09	10.13	10.27	5.75	3.70	2.60	4.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	190.00	19.21	23.60	16.19	16.94	13.16	15.58	10.89	8.32	5.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	164.86	16.84	0.54	1.97	0.72	2.15	1.43	0.72	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	159.81	16.64	19.65	15.06	10.90	13.48	7.75	3.30	3.44	5.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	155.39	15.56	12.56	8.91	7.73	6.55	7.51	5.58	3.65	3.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	158.43	17.04	10.62	9.74	12.17	11.06	8.85	4.20	5.97	9.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	184.68	12.81	7.07	7.46	8.99	8.22	3.25	1.53	2.68	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	157.07	19.01	7.64	7.83	6.52	6.99	5.40	3.26	3.07	2.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	283.18	24.62	18.98	11.65	10.71	7.89	12.03	3.76	6.95	3.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	170.26	15.00	4.91	7.43	4.11	6.77	3.98	1.46	1.86	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	220.67	22.68	29.10	16.06	15.87	14.99	11.97	8.27	5.65	5.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	175.30	19.29	13.75	11.27	13.37	14.51	10.31	3.06	8.02	9.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	152.39	17.30	9.40	7.48	5.02	7.16	4.81	2.88	1.50	2.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	160.62	18.50	23.27	16.54	12.05	11.49	10.93	7.57	4.20	5.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	182.86	18.46	16.41	7.69	12.65	15.89	8.54	5.64	6.49	9.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	141.12	12.76	4.19	3.10	2.19	5.47	1.46	2.01	0.91	2.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	163.96	15.08	23.30	13.86	13.24	10.79	12.14	9.44	5.76	6.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	184.56	20.55	12.09	11.15	10.61	10.07	5.37	2.69	5.10	4.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	178.32	17.22	12.03	12.97	10.61	14.15	5.19	4.72	0.94	5.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	155.56	14.68	20.04	11.71	13.10	12.70	9.33	8.73	4.17	3.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	163.69	19.41	13.33	8.65	11.93	11.46	8.65	3.04	4.91	7.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	147.01	13.48	9.33	9.33	9.33	11.40	5.18	3.11	2.07	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	171.66	13.27	13.72	15.04	5.97	9.29	7.08	4.20	3.54	3.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	146.85	21.31	10.44	6.68	6.68	7.31	6.48	2.72	3.76	5.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	166.62	17.09	15.88	9.82	8.21	11.44	7.00	4.71	3.50	4.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	170.64	13.96	5.28	3.24	4.09	2.90	4.26	1.87	2.21	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	180.07	22.75	14.85	7.71	13.69	12.92	11.76	3.47	6.56	6.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	176.92	13.07	17.19	15.82	12.90	12.55	8.42	4.13	3.78	4.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	133.47	13.17	8.50	4.12	5.35	4.39	5.21	3.15	4.12	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	197.50	16.75	16.42	14.94	10.18	14.61	8.87	5.09	7.22	6.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	156.63	14.66	10.91	8.18	8.01	7.50	4.77	2.05	1.70	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	173.26	16.13	24.71	10.65	10.50	15.24	10.50	3.85	5.92	5.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	188.72	18.13	6.93	5.86	3.73	5.06	4.26	2.67	2.67	4.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	146.70	13.83	7.05	5.53	6.08	5.12	3.59	1.80	1.66	2.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	116.19	10.95	5.95	8.10	5.95	4.52	4.52	0.95	3.57	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	254.95	24.79	7.86	3.02	8.87	6.85	5.44	1.61	2.82	3.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	129.96	11.02	7.72	6.40	7.53	7.82	3.20	3.20	2.45	3.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	170.84	15.37	38.08	17.47	20.61	23.06	20.26	9.08	10.13	10.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	166.52	16.02	7.56	6.65	4.53	5.74	4.53	1.51	3.32	5.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	146.13	11.01	10.28	7.96	6.85	7.59	4.41	2.81	2.45	4.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	524.13	40.61	6.11	9.17	4.22	5.97	4.80	4.08	3.06	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	170.36	12.17	5.48	4.87	3.04	3.65	3.65	0.00	0.61	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	130.20	6.93	4.82	7.23	3.62	6.63	1.51	1.21	2.11	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	134.36	10.86	7.69	5.88	4.75	6.11	4.30	2.49	2.71	4.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	244.72	20.07	29.65	11.98	18.27	15.28	11.08	4.49	8.09	8.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	165.30	13.81	4.72	3.66	3.31	3.42	3.07	0.83	1.06	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	95.41	11.10	0.85	0.43	2.56	4.70	1.07	0.00	2.13	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	218.15	22.84	1.80	0.60	3.00	7.21	4.81	6.01	7.81	4.81
Schwann Cells, donor1	11498-119F4	7.71	1.69	0.00	0.38	0.00	0.00	0.00	0.00	0.00	0.19
Schwann Cells, donor2	11578-120F3	17.01	10.21	3.40	0.00	0.00	3.40	0.00	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	16.21	2.41	1.97	4.60	0.88	0.88	0.88	1.31	0.66	0.66
Sebocyte, donor1	11220-116B5	14.79	5.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	15.17	6.89	0.92	0.00	1.38	0.00	0.46	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	7.42	2.68	0.21	0.00	0.21	0.41	0.41	0.00	0.21	0.00
Sertoli Cells, donor1	11255-116F4	31.48	1.66	0.00	1.66	0.00	1.66	0.00	3.31	0.00	0.00
Sertoli Cells, donor2	11333-117F1	48.01	11.30	11.30	2.82	0.00	0.00	0.00	0.00	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	33.96	5.54	1.41	0.62	0.62	1.06	0.44	0.26	0.26	0.18
Skeletal Muscle Cells, donor2	11358-117H8	1.45	2.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	14.21	4.18	0.00	0.00	0.00	0.00	0.00	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	54.04	10.05	0.79	2.04	1.10	1.26	0.16	0.63	0.16	0.31
Skeletal Muscle Cells, donor5	11455-119A6	44.15	9.96	0.74	1.93	1.34	1.19	0.74	0.59	0.30	0.74
Skeletal Muscle Cells, donor6	11459-119B1	61.25	14.01	2.46	1.69	1.54	1.85	1.08	0.31	1.23	1.54
Skeletal Muscle Satellite Cells, donor1	11240-116D7	68.80	10.58	2.52	1.39	0.88	1.13	1.26	1.64	0.76	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	44.38	7.28	3.57	3.14	2.43	2.85	1.28	1.00	1.57	1.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	57.94	13.29	2.78	1.69	2.48	1.88	0.60	1.59	0.89	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	40.69	4.21	2.36	1.18	0.67	0.93	0.93	0.42	0.76	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.07	1.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	6.88	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skin - palm, donor1	10286-104F7	112.82	42.98	5.37	0.00	26.86	2.69	21.49	5.37	8.06	8.06
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	10.38	4.18	0.72	0.72	0.72	0.14	0.00	0.14	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	305.89	78.52	11.45	7.36	5.73	1.64	4.09	4.09	1.64	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	9.35	2.86	0.13	0.52	0.13	0.13	0.00	0.13	0.13	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	28.22	9.04	1.11	1.39	0.14	0.00	0.00	0.83	0.14	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	31.51	10.13	2.11	0.70	0.84	0.98	1.41	0.28	0.56	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	354.17	75.27	8.88	6.55	5.92	7.19	5.07	3.59	3.59	2.11
Small Airway Epithelial Cells, donor3	11406-118E2	29.46	11.84	3.75	1.65	1.87	0.90	1.72	0.60	0.52	0.82
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	7.10	2.47	0.00	0.93	1.23	0.62	0.31	0.00	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	74.70	9.34	2.00	2.89	2.45	3.33	2.89	1.33	1.11	2.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	18.81	3.53	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	8.18	0.66	0.00	0.22	0.22	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	6.69	0.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	18.54	3.86	0.00	0.77	0.00	0.00	0.00	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	27.02	2.00	1.00	3.00	1.00	0.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	5.46	1.73	0.00	0.13	0.00	0.00	0.00	0.00	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	30.14	4.65	4.43	1.77	2.66	5.54	1.77	1.77	0.89	2.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	14.34	3.33	0.13	0.00	0.00	0.13	0.00	0.00	0.00	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	34.51	4.88	0.33	0.98	0.00	0.00	0.33	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	38.69	4.73	0.59	0.89	0.30	0.30	0.00	0.30	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	25.91	3.99	0.28	1.14	0.28	0.28	0.28	0.85	0.28	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.07	0.49	0.33	0.00	0.00	0.00	0.00	0.00	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	13.09	2.74	1.22	1.22	0.91	0.61	1.22	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	8.59	1.52	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.20	1.43	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	33.33	4.28	0.88	1.18	0.29	0.44	0.29	0.29	0.44	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	30.13	4.09	1.72	1.08	0.86	0.22	0.65	0.65	0.65	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	35.90	4.93	1.36	1.47	1.36	0.63	0.00	0.42	0.21	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	7.27	2.63	0.15	0.00	0.15	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	2.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.97	2.99	0.30	0.60	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	7.85	1.71	0.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	39.97	5.18	2.12	2.28	0.71	1.65	0.55	0.86	0.31	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	32.91	6.94	1.31	1.01	1.41	0.81	0.91	0.70	0.81	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	25.26	3.87	3.41	2.50	1.37	0.23	1.37	0.46	0.91	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.04	1.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	78.42	18.54	4.77	4.24	4.24	2.65	1.32	1.32	1.85	2.38
Smooth Muscle Cells - Prostate, donor1	11257-116F6	35.82	3.99	0.93	0.40	0.13	1.46	0.53	1.07	0.27	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	34.94	5.38	6.14	3.63	2.88	5.01	4.01	2.50	2.13	1.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	16.74	1.52	0.51	0.25	0.25	0.51	0.76	0.00	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	17.19	2.11	0.00	0.30	0.15	0.30	0.15	0.15	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	9.75	0.75	0.75	0.00	0.75	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	16.80	1.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.49	1.86	0.00	0.47	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	16.16	4.54	0.50	0.50	0.00	1.51	0.50	1.51	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.64	0.94	0.00	0.00	0.31	0.63	0.00	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.06	0.59	0.29	0.00	0.00	0.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	48.15	6.50	0.33	0.42	0.17	0.42	0.25	0.08	0.08	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	10.28	2.34	0.93	0.00	0.47	0.47	0.93	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	5.61	2.45	0.00	0.00	0.00	0.00	0.00	0.00	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	15.30	4.33	0.25	0.25	0.51	0.51	0.25	0.00	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.09	2.63	0.00	0.00	0.00	0.00	0.19	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	43.32	8.80	1.68	1.12	0.14	0.98	0.28	0.70	0.70	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	16.76	4.19	0.34	0.42	0.08	0.25	0.08	0.08	0.08	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.38	2.38	0.00	0.00	0.48	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	5.87	2.20	0.00	0.24	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	27.18	5.30	0.66	1.33	0.44	0.44	0.22	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	31.89	3.80	0.59	0.29	1.17	0.29	0.00	0.00	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	26.24	2.53	2.53	1.75	1.75	1.75	1.75	0.78	0.58	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	20.89	2.38	1.59	1.59	1.85	0.26	1.32	1.32	0.26	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	37.19	4.09	6.70	2.60	2.60	2.23	2.98	1.49	0.74	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	31.98	4.31	3.95	2.52	2.16	1.44	1.44	1.80	1.08	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	17.32	5.96	0.57	0.28	0.57	0.85	0.00	0.00	1.14	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	47.66	3.54	4.73	1.97	3.15	1.97	1.58	1.58	0.39	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	29.97	4.57	2.29	1.78	1.78	1.78	2.54	3.05	1.02	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	16.77	3.99	1.60	3.19	0.00	1.20	0.80	0.00	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	17.97	2.51	0.84	2.09	2.09	1.25	0.42	0.00	0.00	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	13.29	2.75	0.92	0.92	0.00	0.92	0.46	0.92	0.00	0.92
Synoviocyte, donor1	11291-117A4	25.08	3.37	1.18	1.51	0.50	1.51	0.17	0.17	0.17	1.18
Synoviocyte, donor2	11368-117I9	21.29	0.67	1.84	1.34	1.01	0.67	0.67	0.50	0.34	0.34
Synoviocyte, donor3	11440-118H9	16.76	2.23	2.68	1.12	0.89	2.46	1.56	0.22	0.67	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	17.51	1.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	1.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	8.80	2.78	0.00	0.46	0.23	0.23	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	10.82	4.44	0.29	0.07	0.14	0.22	0.29	0.00	0.14	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	9.28	3.09	0.00	0.77	0.39	0.00	0.77	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	4.01	5.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	100.76	21.65	4.92	1.97	1.11	1.97	1.97	1.11	1.60	0.98
Urethra, donor2	10319-105A4	109.70	21.58	5.40	3.60	12.59	5.40	16.19	5.40	3.60	8.99
Urothelial Cells, donor1	11520-119H8	2.13	0.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	1.60	1.20	0.00	0.40	0.00	0.80	0.00	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	2.75	1.15	0.46	0.00	0.00	0.00	0.00	0.00	0.23	0.00
Urothelial cells, donor0	11216-116B1	25.63	6.69	1.11	1.34	0.67	0.45	0.45	0.22	0.67	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	88.09	21.35	10.68	2.67	1.78	0.89	0.89	0.89	0.89	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	85.78	28.59	2.86	2.86	4.29	1.43	2.86	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	63.66	21.22	10.95	6.16	6.16	3.42	4.11	2.74	0.68	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	84.36	14.12	3.10	3.44	2.41	1.38	2.75	2.75	1.03	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	74.37	14.53	2.91	2.32	1.74	1.16	1.16	1.16	1.16	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	107.25	20.82	6.25	1.04	1.04	3.12	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	85.35	20.19	11.01	5.51	2.75	2.75	0.92	0.92	0.92	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	69.38	12.78	11.87	5.48	1.83	1.83	3.65	0.00	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	102.88	14.93	7.15	5.30	4.69	4.69	4.81	3.33	2.22	3.33
Wilms' tumor cell line:HFWT	10597-108E3	89.76	19.36	0.00	2.64	4.40	2.64	5.28	1.76	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	72.62	13.97	8.38	6.70	5.59	6.70	7.54	4.47	1.96	0.84
achilles tendon, donor2	10292-104G4	59.93	26.86	4.13	0.00	6.20	10.33	10.33	4.13	8.27	6.20
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	156.54	28.30	20.14	18.61	14.28	10.20	15.81	7.65	9.18	7.39
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	236.82	26.00	10.91	6.97	7.89	10.91	4.41	3.95	4.88	1.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	291.07	42.50	10.33	6.77	8.55	4.27	7.12	3.68	4.75	2.85
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	176.87	25.03	21.22	15.78	12.52	12.25	16.60	10.34	7.62	4.35
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	178.49	16.58	34.57	24.74	16.87	19.96	12.37	13.21	7.31	7.31
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	139.15	16.92	1.27	4.23	1.06	1.48	1.90	1.06	0.63	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	131.48	21.78	12.79	8.71	11.43	10.34	13.61	7.08	6.81	3.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	167.00	42.30	19.39	19.83	16.74	15.42	10.58	10.13	5.29	6.61
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	213.57	34.30	31.85	23.68	17.15	19.19	16.33	22.05	10.21	6.53
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	150.27	16.70	13.98	9.71	13.20	5.82	10.10	10.48	3.49	3.49
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	154.56	42.32	44.16	18.95	20.61	20.06	16.38	10.30	6.99	7.54
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	495.37	58.51	3.90	0.00	3.90	7.80	7.80	3.90	0.00	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	126.65	17.43	21.61	10.22	12.55	16.73	7.44	6.97	5.58	4.65
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	224.21	57.99	42.98	24.34	20.97	19.68	15.28	17.86	9.06	11.91
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	186.45	51.14	62.25	36.24	23.67	23.67	25.13	21.33	12.86	6.14
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	107.82	40.43	10.69	1.86	1.39	3.25	4.65	1.86	2.79	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	89.65	29.61	6.58	4.52	3.29	3.70	6.99	3.70	1.65	2.88
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	27.32	3.99	1.23	0.31	0.92	0.31	2.15	0.61	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	106.25	25.18	5.97	4.27	3.41	2.56	3.84	2.56	0.85	1.71
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	106.46	31.24	3.34	3.64	3.03	2.43	2.12	0.91	0.61	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	127.57	36.11	3.37	1.68	1.93	0.72	2.89	1.44	1.68	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	100.46	30.96	19.60	11.36	8.91	12.47	8.69	6.01	6.01	3.79
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	174.11	31.69	10.01	4.00	5.34	4.34	6.34	1.33	2.67	2.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	308.46	66.90	9.29	1.86	5.57	3.72	9.29	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	167.99	36.91	13.94	9.42	8.29	10.17	6.03	5.65	3.39	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	266.04	21.37	15.70	6.54	7.85	3.05	6.11	1.31	3.49	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	455.49	46.86	1.87	1.87	1.87	3.75	7.50	1.87	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	41.21	9.66	2.35	1.18	1.41	3.06	1.18	0.71	0.71	0.94
adipose tissue, adult, pool1	10010-101C1	43.12	7.60	1.55	0.78	0.16	0.93	0.47	0.31	0.16	0.00
adipose, donor1	10184-103D4	442.15	53.95	52.19	45.15	38.70	42.22	25.80	17.59	14.66	12.31
adipose, donor2	10185-103D5	37.71	15.82	4.87	5.27	2.43	2.84	4.46	1.62	1.62	1.62
adipose, donor3	10186-103D6	97.21	16.34	10.35	8.44	6.26	7.35	9.80	4.36	4.08	2.18
adipose, donor4	10187-103D7	138.68	17.34	19.94	25.14	13.87	11.27	18.20	16.47	7.80	4.33
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	70.23	11.52	2.21	1.10	1.26	1.89	1.26	0.16	1.10	1.89
adrenal gland, adult, pool1	10081-102A9	14.55	3.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	92.45	30.28	3.87	2.00	4.27	2.00	2.40	1.47	2.13	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	78.96	14.65	7.86	5.00	3.93	4.64	5.36	3.57	2.50	1.79
amniotic membrane cells, donor1	12235-129G3	27.59	5.56	0.70	0.93	0.00	0.46	0.46	0.46	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	31.44	3.38	1.01	0.68	1.01	0.68	0.00	1.01	0.68	0.34
amniotic membrane cells, donor3	12237-129G5	43.60	9.43	2.06	2.95	0.59	0.88	0.29	0.59	0.59	0.00
amygdala - adult, donor10196	10167-103B5	105.54	3.56	14.23	8.30	10.67	7.11	10.67	1.19	3.56	3.56
amygdala, adult, donor10252	10151-102I7	136.67	20.89	10.34	6.08	10.54	7.50	8.72	2.64	3.85	1.82
amygdala, newborn, donor10223	10360-105E9	40.67	9.36	4.84	1.29	0.97	1.61	1.29	1.29	0.32	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	73.85	18.84	3.06	2.29	1.66	1.02	1.15	1.53	0.76	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	86.93	20.08	14.12	9.71	10.15	8.38	6.40	4.85	3.09	1.54
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	341.39	36.74	25.72	12.03	24.38	16.70	17.70	11.36	8.35	5.01
aorta, adult, pool1	10052-101G7	28.44	10.40	2.35	1.37	0.78	2.55	1.77	0.78	0.39	1.57
appendix, adult	10189-103D9	131.57	21.35	1.16	1.55	2.33	1.16	2.72	0.00	2.33	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	167.50	23.39	14.79	11.01	5.16	7.22	8.94	6.88	4.13	2.41
artery, adult	10190-103E1	39.40	8.15	1.36	2.72	4.08	0.00	2.72	2.72	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	152.11	12.17	3.48	2.32	3.19	2.75	2.61	1.16	1.30	1.01
b cell line:RPMI1788	10427-106D4	135.17	35.54	5.65	5.06	3.12	3.27	2.97	3.12	2.53	1.34
basal cell carcinoma cell line:TE 354.T	10702-109G9	35.24	3.33	1.39	0.83	0.28	0.55	0.83	0.28	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	103.80	18.66	2.88	2.18	1.39	1.79	0.50	1.29	0.99	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	90.55	14.23	8.37	3.18	2.51	4.02	1.34	1.51	2.01	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	57.60	20.13	5.03	2.80	4.47	3.91	2.24	0.56	0.00	1.68
bladder, adult, pool1	10011-101C2	67.79	13.15	1.09	1.63	1.20	0.98	2.39	0.76	1.52	0.22
blood, adult, pool1	10053-101G8	19.93	13.29	2.21	2.21	0.00	0.00	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	79.64	3.43	0.86	0.00	0.00	0.86	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	71.53	11.47	14.85	7.42	4.72	6.75	6.75	6.07	6.07	8.10
brain, adult, donor1	10084-102B3	15.38	8.20	3.08	0.00	0.00	0.00	2.05	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	59.13	9.35	3.12	2.67	2.45	1.67	1.67	1.22	1.11	0.89
brain, fetal, pool1	10085-102B4	13.36	10.69	5.34	2.67	0.00	0.00	5.34	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	205.82	28.74	6.94	6.94	6.94	5.62	11.23	3.96	4.29	3.30
breast carcinoma cell line:MDA-MB-453	10419-106C5	205.96	23.72	4.99	1.75	1.87	2.37	2.37	1.25	1.37	1.00
breast, adult, donor1	10080-102A8	22.10	6.94	1.26	0.63	0.63	0.00	0.63	0.00	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	75.84	12.58	10.54	6.22	8.26	6.73	5.59	2.03	2.54	2.92
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	171.62	24.12	15.46	14.22	11.75	13.30	11.75	6.18	3.09	4.02
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	144.12	34.30	4.83	7.83	5.30	3.45	2.07	2.99	2.53	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	57.13	11.86	11.86	5.81	4.84	3.63	6.29	2.91	2.66	2.42
carcinoid cell line:NCI-H1770	10703-109H1	115.66	45.14	6.11	4.70	5.17	3.29	3.29	4.70	4.70	2.35
carcinoid cell line:NCI-H727	10735-110B6	72.08	11.38	1.09	1.09	1.20	0.55	1.20	0.33	0.55	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	135.63	23.13	10.77	10.46	6.65	9.82	8.87	7.29	7.29	6.34
carcinosarcoma cell line:JHUCS-1	10642-109A3	221.46	30.88	31.41	25.55	15.70	19.96	12.51	8.52	8.25	6.39
caudate nucleus - adult, donor10196	10177-103C6	97.86	28.78	1.15	2.30	3.45	5.76	4.61	2.30	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	98.72	19.24	10.21	3.68	7.20	6.86	5.19	1.84	3.35	2.34
caudate nucleus, adult, donor10258	10379-105H1	39.74	6.11	8.41	5.35	3.82	2.29	2.29	0.76	2.29	0.76
caudate nucleus, newborn, donor10223	10354-105E3	56.03	15.02	3.30	1.46	1.83	0.73	2.56	0.37	1.10	1.10
cerebellum - adult, donor10196	10173-103C2	230.15	29.13	11.65	5.83	8.74	14.57	5.83	5.83	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	265.18	29.89	25.41	6.83	13.24	10.03	11.32	3.20	7.26	5.76
cerebellum, adult, pool1	10083-102B2	48.29	8.62	6.21	5.86	6.90	2.76	4.14	2.76	1.72	1.72
cerebellum, newborn, donor10223	10357-105E6	146.13	21.59	17.44	3.32	9.96	8.30	9.96	3.32	4.15	1.66
cerebral meninges, adult	10188-103D8	62.53	10.84	1.26	0.00	2.52	1.76	2.27	0.50	2.77	0.50
cerebrospinal fluid, donor2	10294-104G6	42.39	8.04	1.46	4.39	5.85	4.39	4.39	2.19	2.92	4.39
cervical cancer cell line:D98-AH2	10552-107I3	117.76	31.06	2.88	4.17	2.88	2.16	1.73	2.59	0.58	1.29
cervical cancer cell line:ME-180	10553-107I4	110.37	22.04	3.15	2.49	0.99	2.49	1.16	0.99	0.50	0.66
cervix, adult, pool1	10013-101C4	97.75	19.11	3.15	1.57	1.99	1.47	2.52	0.84	1.47	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	69.95	14.07	1.39	3.62	0.98	0.70	0.42	1.11	0.14	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	24.82	9.14	0.00	0.00	1.31	0.00	1.31	0.00	0.00	2.61
choriocarcinoma cell line:BeWo	10423-106C9	163.92	32.93	7.58	5.22	4.35	3.73	5.34	4.72	2.36	1.24
choriocarcinoma cell line:SCH	10785-110H2	94.26	15.40	10.23	9.61	8.50	7.27	6.28	5.67	3.08	2.59
choriocarcinoma cell line:T3M-3	10618-108G6	110.76	24.90	4.51	3.32	1.90	1.66	1.42	1.90	2.37	1.66
chorionic membrane cells, donor1	12238-129G6	33.05	7.12	0.57	1.42	0.00	0.28	0.85	0.85	1.14	0.57
chorionic membrane cells, donor2	12239-129G7	38.58	4.77	0.40	0.80	0.40	0.40	0.30	0.60	0.20	0.10
chorionic membrane cells, donor3	12240-129G8	43.41	8.79	3.85	7.69	1.65	5.49	0.00	1.65	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	92.90	16.16	7.07	13.13	6.06	7.07	4.04	3.03	1.01	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	80.11	16.52	5.19	3.84	4.61	2.88	1.73	2.11	3.07	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	136.43	24.08	4.86	4.65	2.32	3.38	4.43	2.11	0.84	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	117.87	28.76	10.02	5.39	3.85	2.57	2.82	2.57	1.80	2.31
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	129.40	25.64	5.08	2.90	5.32	2.66	4.11	0.73	1.45	2.18
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	137.64	27.49	11.40	2.65	5.70	3.66	6.11	1.02	2.44	2.24
chronic myelogenous leukemia cell line:K562	10454-106G4	163.72	28.56	10.60	2.94	4.12	4.71	7.07	2.65	2.94	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	324.74	50.04	5.99	5.21	5.47	5.99	4.95	4.43	1.04	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	76.57	8.00	5.26	8.23	4.34	5.94	3.43	4.57	2.97	2.97
clear cell carcinoma cell line:TEN	10636-108I6	159.45	25.33	3.30	4.51	2.95	2.08	4.68	2.08	2.60	1.39
colon carcinoma cell line:CACO-2	10513-107D9	109.28	10.07	1.83	1.28	1.46	1.10	0.55	1.28	0.92	0.73
colon carcinoma cell line:COLO-320	10420-106C6	255.79	47.89	6.84	6.84	5.32	3.80	6.84	5.32	3.04	2.28
colon, adult, donor1	10082-102B1	19.04	5.95	0.00	0.00	0.00	0.00	1.19	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	79.31	11.05	2.12	0.82	1.18	0.59	2.23	0.24	0.59	0.35
colon, fetal, donor1	10070-101I7	58.71	17.30	2.47	0.62	3.71	0.62	4.33	0.00	1.24	0.62
common myeloid progenitor CMP, donor1	12130-128D6	1617.98	201.67	0.00	0.00	4.58	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	195.89	31.45	5.10	2.55	2.55	3.82	2.55	2.12	2.55	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	128.74	15.40	1.96	2.26	1.96	1.96	2.26	2.11	1.36	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	155.54	20.59	5.64	3.24	2.68	3.38	2.82	2.40	3.53	1.55
corpus callosum, adult, pool1	10042-101F6	95.53	18.13	3.65	1.33	1.55	1.77	1.22	0.88	1.22	0.77
cruciate ligament, donor2	10295-104G7	85.10	15.40	0.81	4.86	10.54	4.86	3.24	1.62	7.29	4.05
diaphragm, fetal, donor1	10069-101I6	33.71	8.83	2.41	0.80	0.80	0.80	1.61	1.61	1.61	0.00
diencephalon, adult	10193-103E4	54.48	8.16	5.52	2.64	4.32	3.60	3.36	1.44	2.88	2.64
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	191.50	27.78	39.95	36.97	21.12	20.67	18.14	22.27	9.18	12.40
ductal cell carcinoma cell line:KLM-1	10438-106E6	158.22	28.98	3.59	2.82	1.03	2.31	2.56	0.51	0.77	1.54
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	78.96	19.74	5.78	3.37	5.30	2.41	5.06	2.17	1.44	0.48
ductus deferens, adult	10196-103E7	94.19	19.44	3.99	1.50	3.99	3.49	1.50	0.50	0.50	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	31.69	4.32	7.20	10.08	8.64	8.64	10.08	5.76	2.88	5.76
duodenum, fetal, donor1, tech_rep2	10071-101I8	158.16	18.39	22.81	15.45	12.51	18.39	16.92	8.83	5.15	8.09
dura mater, adult, donor1	10041-101F5	96.38	16.68	1.90	1.07	1.57	1.16	1.32	0.33	0.91	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	94.16	36.42	1.33	2.00	1.11	2.22	1.33	1.33	1.11	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	108.47	16.62	3.01	2.29	1.86	1.43	2.72	0.72	0.57	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	104.82	23.43	2.47	1.85	1.85	3.08	4.93	2.47	1.23	2.47
embryonic pancreas cell line:1C3D3	10605-108F2	64.17	16.65	2.42	3.33	2.72	0.91	1.51	1.51	0.91	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	115.47	30.57	3.09	1.54	1.23	3.09	3.09	0.93	0.93	1.54
embryonic pancreas cell line:2C6	10603-108E9	135.29	26.27	1.31	2.63	2.63	1.31	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	94.19	10.39	1.34	2.35	1.34	1.34	2.35	0.67	0.34	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	66.69	14.68	10.51	7.79	5.26	4.17	5.80	4.89	2.54	1.99
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	60.79	6.11	8.04	7.24	4.02	5.79	3.06	3.22	1.77	2.25
epidermoid carcinoma cell line:A431	10426-106D3	118.27	18.23	4.11	1.33	1.89	1.67	2.11	0.56	0.67	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	131.76	23.98	3.63	2.53	2.20	1.98	1.76	1.54	1.98	0.77
epididymis, adult	10197-103E8	138.98	20.30	7.95	3.98	9.21	4.81	9.42	1.05	5.65	3.14
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	51.09	7.10	5.14	4.08	2.48	2.48	3.73	1.95	1.95	2.31
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	45.62	10.22	3.15	2.75	2.36	0.39	0.39	3.54	1.18	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	185.17	29.88	13.24	11.93	11.01	14.55	9.04	5.11	4.46	7.47
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	259.83	44.39	19.98	11.81	12.89	12.79	10.73	5.31	7.87	8.86
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	181.15	30.47	16.36	11.09	9.19	11.76	8.40	5.71	5.71	5.27
esophagus, adult, pool1	10015-101C6	52.56	9.03	0.74	0.85	1.59	0.53	1.27	0.32	1.17	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	233.69	36.07	4.88	1.88	1.75	1.63	3.38	1.63	1.75	0.50
eye - muscle inferior rectus, donor1	10272-104E2	173.85	31.39	2.41	4.83	14.49	14.49	14.49	14.49	14.49	12.07
eye - muscle lateral, donor2	10298-104H1	82.06	6.31	2.10	4.21	6.31	4.21	4.21	4.21	4.21	12.63
eye - muscle medial, donor2	10299-104H2	114.59	17.86	2.98	1.49	10.42	5.95	8.93	1.49	2.98	7.44
eye - muscle superior, donor2	10297-104G9	92.87	18.34	0.00	0.00	5.73	3.44	8.03	0.00	6.88	5.73
eye - vitreous humor, donor1	10268-104D7	62.67	11.66	2.91	4.37	5.83	1.46	4.37	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	51.10	16.02	5.59	2.29	2.54	3.31	2.80	2.54	1.27	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	68.60	16.80	7.95	3.59	2.95	4.23	3.59	3.08	1.80	2.44
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	83.33	23.27	8.07	5.70	5.70	7.12	3.32	5.22	3.09	3.32
frontal lobe, adult, pool1	10040-101F4	88.85	14.36	3.10	1.22	1.13	1.69	1.78	0.94	0.75	1.03
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	265.12	21.02	38.73	23.72	26.12	19.22	23.12	14.11	8.41	9.01
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	82.29	18.56	1.28	1.01	1.10	0.73	1.10	0.37	0.37	0.46
gall bladder, adult	10198-103E9	51.18	10.86	1.93	1.21	2.90	2.17	1.69	0.97	0.97	0.48
gamma delta positive T cells, donor1	11937-126A2	138.51	23.62	2.15	2.68	1.07	0.54	0.54	1.61	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	131.10	15.69	1.49	3.36	1.12	0.00	1.49	1.12	0.75	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	34.22	5.07	3.17	4.65	2.53	2.11	3.59	2.53	0.84	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	115.86	23.60	12.96	10.06	7.74	7.16	6.00	4.45	3.29	1.93
gastric cancer cell line:AZ521	10549-107H9	152.81	21.97	4.43	3.28	2.46	1.31	2.13	1.15	1.64	0.66
gastric cancer cell line:GSS	10560-108A2	46.68	23.80	4.58	4.58	3.66	0.92	1.83	2.75	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	246.28	36.32	31.53	27.41	14.39	16.45	9.60	9.82	6.40	6.40
giant cell carcinoma cell line:LU65	10487-107B1	83.88	29.83	5.74	4.36	3.44	3.44	3.67	2.87	1.26	0.80
giant cell carcinoma cell line:Lu99B	10433-106E1	113.93	25.75	3.22	1.54	2.10	2.38	1.54	1.68	0.70	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	113.73	22.20	7.23	4.49	2.99	5.49	7.23	2.74	2.74	2.24
glioblastoma cell line:A172, tech_rep1	10444-106F3	75.05	7.71	3.06	2.01	1.27	0.95	2.32	0.63	1.06	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	69.80	8.15	5.06	3.65	2.81	1.83	4.07	1.97	1.69	1.40
glioblastoma cell line:T98G	10485-107A8	76.93	9.27	3.86	2.98	1.77	1.99	1.55	1.99	2.21	1.66
glioma cell line:GI-1	10413-106B8	90.79	5.56	1.17	0.59	2.05	1.17	0.88	0.88	1.17	0.00
globus pallidus - adult, donor10196	10175-103C4	67.06	13.12	3.64	1.46	0.73	2.92	2.19	0.73	2.92	2.19
globus pallidus, adult, donor10252	10161-103A8	212.36	47.84	13.43	8.30	10.01	5.37	10.25	4.39	4.39	4.39
globus pallidus, adult, donor10258	10367-105F7	95.84	30.12	10.95	5.48	6.85	0.00	5.48	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	32.51	9.59	0.53	0.53	0.53	1.07	0.53	0.53	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	854.05	141.93	2.45	0.00	2.45	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	32.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	57.49	15.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	55.04	5.12	1.28	0.96	1.28	0.96	1.92	0.96	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	124.88	15.61	13.31	5.05	5.05	5.51	4.13	1.38	1.38	1.84
hIPS +CCl2, biol_rep2	14384-156C1	131.69	15.55	18.29	8.69	9.15	6.86	5.94	3.66	3.20	2.74
hIPS +CCl2, biol_rep3	14385-156C2	97.90	5.15	16.10	7.09	6.44	5.15	3.22	4.51	2.58	1.29
hIPS, biol_rep1	14380-156B6	102.05	8.62	10.06	2.87	1.44	5.75	2.87	5.75	0.00	2.87
hIPS, biol_rep2	14381-156B7	89.85	6.17	8.92	6.86	6.17	4.80	4.12	0.69	3.43	1.37
hIPS, biol_rep3	14382-156B8	66.21	8.83	13.24	6.62	5.52	0.00	2.21	1.10	4.41	1.10
hairy cell leukemia cell line:Mo	10712-109I1	86.20	20.40	11.78	8.62	9.48	6.32	5.75	6.03	3.74	3.16
heart - mitral valve, adult	10205-103F7	78.63	12.86	2.99	3.29	0.90	2.39	1.79	0.90	1.49	1.20
heart - pulmonic valve, adult	10206-103F8	112.70	14.64	5.49	4.97	6.01	3.66	4.97	3.40	3.40	4.18
heart - tricuspid valve, adult	10207-103F9	97.42	28.31	5.83	3.33	2.50	0.83	5.00	2.50	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	51.42	6.12	6.73	5.92	3.06	1.43	1.84	2.65	1.22	1.22
heart, adult, diseased, donor1	10051-101G6	12.35	4.68	0.85	1.28	0.43	0.85	0.85	0.85	0.00	0.43
heart, adult, pool1	10016-101C7	22.77	8.28	0.23	0.00	0.23	0.23	0.23	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	82.45	12.63	2.57	1.44	1.03	1.54	1.44	0.41	0.92	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	34.25	5.24	2.16	1.23	0.62	0.62	0.93	0.62	1.54	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	355.56	64.22	3.57	1.19	5.95	4.76	11.89	1.19	1.19	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	346.18	51.16	23.65	13.70	14.03	14.14	13.37	7.29	7.85	9.50
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	353.32	50.37	21.97	12.14	17.60	15.17	11.53	6.55	7.53	9.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	432.00	62.55	30.01	11.01	19.10	17.28	15.66	8.49	8.99	10.41
hepatoma cell line:Li-7	10484-107A7	74.74	12.23	4.78	2.89	1.78	2.78	2.22	1.67	1.78	1.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	123.82	18.39	10.65	7.64	5.73	7.14	4.32	3.72	2.41	3.12
hippocampus - adult, donor10196	10169-103B7	88.01	10.41	12.30	3.79	14.19	4.73	6.62	0.00	2.84	1.89
hippocampus, adult, donor10252	10153-102I9	162.67	21.43	13.67	8.98	9.80	6.94	10.61	3.06	5.10	3.47
hippocampus, adult, donor10258	10374-105G5	83.16	9.96	13.94	5.48	7.47	1.99	3.98	1.49	1.00	2.99
hippocampus, newborn, donor10223	10363-105F3	30.31	5.99	3.88	0.00	1.06	1.06	2.47	1.76	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	233.15	31.13	17.09	14.04	9.77	8.54	6.10	10.99	4.27	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	117.42	15.12	11.78	12.57	7.46	7.27	6.87	4.12	2.75	3.53
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	131.77	19.04	8.38	8.12	6.86	3.55	4.06	3.30	2.03	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	125.18	22.55	7.33	6.20	3.38	5.07	2.82	2.82	2.26	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	180.23	31.24	18.59	29.44	8.52	8.78	7.49	8.78	3.10	4.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	175.38	37.20	9.11	7.21	3.80	3.04	1.52	3.42	3.80	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	182.47	34.16	6.71	4.67	5.55	3.21	2.92	3.50	1.75	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	165.23	28.44	11.42	11.20	6.46	5.60	5.82	2.80	3.66	2.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	158.49	24.61	4.17	3.75	1.25	1.25	5.00	2.09	2.50	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	184.70	14.68	3.08	3.08	1.42	0.47	2.13	1.66	0.47	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	136.77	18.00	10.45	7.55	7.23	5.14	5.30	3.38	3.21	1.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	156.88	12.12	2.02	4.71	1.35	0.67	0.67	0.67	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	131.60	19.87	12.36	11.27	6.89	6.57	6.57	5.16	4.23	3.76
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	156.23	21.62	21.62	28.00	12.77	10.32	8.84	7.37	1.97	2.95
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	196.37	28.80	14.84	8.73	4.36	6.11	4.36	6.11	0.87	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	175.83	29.97	11.84	9.74	6.68	4.77	7.25	4.39	3.05	2.10
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	144.78	26.60	15.26	14.83	4.80	6.98	5.23	6.11	2.18	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	169.92	19.99	9.00	11.99	3.00	1.50	2.50	3.50	5.00	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	71.40	30.14	6.78	3.39	2.83	3.20	3.77	2.26	2.26	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	85.94	23.65	3.64	5.46	1.82	2.73	3.18	2.27	0.45	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	78.94	22.24	5.33	4.70	2.19	1.88	3.45	2.19	0.31	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	99.45	11.27	6.21	6.86	3.43	2.61	4.08	1.63	1.14	2.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	100.74	9.58	6.68	4.35	3.48	3.77	2.90	1.74	1.45	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	80.71	8.67	4.18	3.29	2.99	1.79	3.59	1.79	1.20	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	141.70	16.26	16.07	14.41	8.50	7.76	8.68	7.94	5.54	4.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	116.40	18.26	10.56	7.99	4.85	7.42	2.28	4.85	1.43	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	182.52	22.05	7.35	11.02	3.27	7.76	4.49	4.49	1.63	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	171.82	17.60	16.55	15.84	6.34	8.45	6.69	2.82	3.17	2.46
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	114.34	15.84	10.45	7.60	5.70	6.97	6.97	3.80	1.90	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	114.69	19.07	7.87	5.14	4.54	1.82	3.63	2.42	2.42	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	101.87	20.17	1.03	2.07	4.65	3.10	2.59	1.55	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	86.34	11.95	4.65	3.32	0.66	3.32	4.65	1.33	1.33	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	132.37	16.16	4.87	3.59	1.03	2.05	3.59	1.54	0.77	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	115.04	8.69	7.93	9.46	4.09	2.56	2.30	1.02	2.56	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	127.97	9.84	3.79	3.03	4.54	5.30	1.51	2.27	3.79	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	89.06	7.39	3.02	3.70	1.34	1.01	2.35	2.02	0.67	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	153.84	19.32	13.28	11.35	7.49	7.97	5.55	4.59	4.11	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	162.22	25.85	8.02	11.59	9.80	7.58	4.01	3.57	1.34	3.12
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	136.10	20.00	4.88	8.29	5.37	3.90	0.98	2.44	1.95	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	168.70	19.87	13.75	12.22	8.56	7.95	6.42	3.67	3.36	3.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	2108.10	172.42	97.60	110.61	35.79	39.04	32.53	22.77	19.52	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	218.09	37.40	8.94	9.27	4.63	3.64	4.63	2.98	2.65	2.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	164.19	27.91	10.95	6.02	3.28	3.28	2.74	1.09	3.83	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	140.05	18.09	5.07	2.17	2.53	2.17	4.34	2.17	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	134.52	28.83	2.49	2.85	2.14	2.14	2.14	1.78	1.07	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	103.82	7.16	4.77	2.39	0.00	0.00	4.77	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	200.84	17.47	6.64	2.03	1.35	2.44	2.30	1.08	0.95	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	91.59	10.78	1.89	3.23	2.16	1.08	2.42	0.81	0.54	0.27
immature langerhans cells, donor1	11904-125F5	125.43	16.22	2.42	0.97	1.21	1.94	0.73	1.21	1.45	0.24
immature langerhans cells, donor2	11905-125F6	81.59	23.76	1.58	3.96	0.00	1.58	0.00	1.58	0.00	0.00
insula, adult, pool1	10039-101F3	58.10	7.95	2.08	0.38	1.61	1.42	1.32	0.76	0.38	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	44.55	5.53	1.95	1.30	1.30	1.30	0.65	1.30	1.30	0.65
kidney, adult, pool1	10017-101C8	56.97	7.01	2.90	1.90	0.80	1.50	1.50	0.50	0.70	1.10
kidney, fetal, pool1	10045-101F9	56.80	9.83	0.92	0.71	0.35	0.42	0.21	0.00	0.28	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	195.14	28.40	1.70	1.85	1.56	1.85	3.27	1.14	0.99	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	58.48	11.20	1.38	4.98	1.94	2.07	2.07	0.69	1.38	1.11
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	46.98	24.04	2.57	0.55	2.02	1.65	0.73	1.10	0.92	0.55
left atrium, adult, donor1	10079-102A7	13.08	3.81	2.18	0.54	0.54	0.54	2.72	0.54	0.54	0.00
left ventricle, adult, donor1	10078-102A6	9.61	5.06	1.52	1.01	1.01	0.51	1.01	1.01	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	117.93	24.35	4.65	2.46	1.37	1.92	3.83	1.09	1.09	1.37
leiomyoma cell line:10964C	10569-108B2	7.54	1.80	0.00	1.44	0.00	0.36	0.00	0.00	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	13.59	1.63	0.00	2.17	0.54	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	22.34	3.40	1.94	2.91	0.73	1.21	1.21	0.49	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	0.00	0.00	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	76.33	9.41	2.09	0.00	3.14	1.05	3.14	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	201.41	31.88	24.79	11.22	14.05	13.46	12.63	8.15	6.02	5.31
liposarcoma cell line:KMLS-1	10782-110G8	41.55	4.22	1.25	1.41	1.56	1.56	0.94	1.41	0.94	0.94
liposarcoma cell line:SW 872	10726-110A6	71.40	8.04	2.56	1.46	2.07	1.10	1.95	0.73	1.34	0.85
liver, adult, pool1	10018-101C9	33.38	6.64	1.78	0.32	0.65	0.32	0.65	0.16	0.32	0.32
liver, fetal, pool1	10086-102B5	11.29	7.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	102.51	18.67	7.58	2.77	5.83	5.25	6.12	1.02	2.33	1.31
locus coeruleus, adult, donor10252	10165-103B3	105.75	20.30	7.57	5.72	9.41	9.60	8.67	2.95	4.24	6.27
locus coeruleus, adult, donor10258	10375-105G6	30.47	8.18	4.23	3.10	1.13	0.85	1.69	1.69	1.13	0.56
locus coeruleus, newborn, donor10223	10362-105F2	98.00	19.77	7.99	0.84	1.26	2.52	3.36	1.68	1.26	2.10
lung adenocarcinoma cell line:A549	10499-107C4	47.05	6.92	0.69	1.25	1.11	0.69	0.55	0.42	0.14	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	141.33	19.99	0.69	0.00	0.00	0.00	0.00	0.69	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	202.87	28.87	5.54	3.82	3.69	2.11	2.90	1.32	1.05	0.40
lung, adult, pool1	10019-101D1	50.20	18.43	2.13	0.95	0.71	0.59	1.06	0.95	0.71	0.35
lung, fetal, donor1	10068-101I5	195.50	37.39	1.71	1.43	4.57	3.42	2.28	0.29	2.57	1.43
lung, right lower lobe, adult, donor1	10075-102A3	38.49	11.91	8.25	5.50	2.75	3.21	2.29	1.37	0.92	1.37
lymph node, adult, donor1	10077-102A5	19.88	6.63	3.31	3.31	2.84	1.42	2.37	0.95	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	74.52	15.78	3.51	2.85	2.63	1.32	2.41	0.88	1.53	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	138.10	11.02	2.57	3.92	4.08	2.87	3.92	1.51	3.17	1.51
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	262.49	43.32	4.25	1.70	0.85	0.85	5.10	0.85	0.85	0.85
mature adipocyte, donor1	12231-129F8	51.06	9.32	0.44	0.00	0.44	0.00	0.89	0.00	0.44	0.44
mature adipocyte, donor2	12232-129F9	46.07	9.96	0.00	0.62	0.62	0.42	0.00	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	44.57	10.67	0.47	0.24	0.00	0.95	0.47	0.00	0.24	0.00
mature adipocyte, donor4	12234-129G2	60.28	6.32	0.00	0.00	0.26	0.00	0.00	0.00	0.79	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	158.68	32.88	3.10	1.19	0.95	0.48	2.62	0.71	1.43	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	83.47	12.41	13.54	2.26	5.64	6.77	1.13	3.38	2.26	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	124.87	20.60	14.16	4.97	7.91	4.97	7.72	2.57	3.86	3.31
medial frontal gyrus, adult, donor10258	10368-105F8	33.04	5.40	6.67	3.18	4.13	3.18	2.86	2.54	1.27	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	152.68	19.62	8.53	3.41	6.40	1.28	8.10	2.99	1.71	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	110.53	15.53	21.26	20.25	4.73	1.69	6.41	4.22	1.01	3.04
medial temporal gyrus, adult, donor10252	10156-103A3	139.22	22.71	14.01	5.52	7.85	5.52	9.76	2.97	6.37	3.61
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	63.57	1.93	25.04	0.00	5.78	3.85	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	2870.72	215.30	301.43	114.83	114.83	57.41	157.89	43.06	157.89	57.41
medial temporal gyrus, newborn, donor10223	10353-105E2	40.92	11.84	3.23	1.79	1.44	0.72	2.15	1.44	1.44	1.08
medulla oblongata - adult, donor10196	10174-103C3	119.41	16.87	8.44	7.14	5.19	3.89	3.89	2.60	3.89	2.60
medulla oblongata, adult, donor10252	10155-103A2	171.83	32.66	13.16	5.57	9.44	6.81	8.67	3.56	4.80	3.56
medulla oblongata, adult, pool1	10038-101F2	53.55	10.12	1.14	0.49	0.98	0.57	0.49	0.57	0.57	0.16
medulla oblongata, newborn, donor10223	10361-105F1	63.53	11.11	2.43	0.69	1.04	1.74	0.69	0.35	1.39	1.39
medulloblastoma cell line:D283 Med	10838-111E1	634.79	88.79	92.11	51.37	40.96	37.64	37.42	27.01	25.68	17.49
medulloblastoma cell line:ONS-76	10759-110E3	73.12	10.03	6.73	1.59	3.55	3.42	3.67	1.22	0.86	1.10
melanoma cell line:COLO 679	10514-107E1	70.15	12.07	1.72	1.58	1.29	1.01	0.86	0.29	0.57	0.72
melanoma cell line:G-361	10465-106H6	60.26	5.43	7.87	2.99	6.79	3.80	5.70	1.63	3.26	2.99
meningioma cell line:HKBMM	10691-109F7	24.60	10.13	3.08	2.17	0.90	1.99	1.45	1.09	0.72	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	404.45	42.30	20.27	20.27	16.74	25.55	14.98	13.22	10.57	5.29
merkel cell carcinoma cell line:MS-1	10844-111E7	173.42	22.29	6.22	7.78	5.44	6.22	5.70	3.37	3.89	2.85
mesenchymal precursor cell - adipose, donor1	11747-123G1	44.50	4.14	1.07	2.61	1.07	1.38	0.92	1.23	0.61	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	34.72	3.45	1.27	2.36	0.73	0.55	0.73	0.91	0.91	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	33.96	3.73	2.07	3.73	1.66	1.24	0.41	0.83	0.00	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	24.72	3.09	1.83	0.84	0.28	0.70	0.56	0.84	0.42	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	25.61	2.12	1.54	1.16	0.58	1.35	0.19	0.77	0.19	1.35
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	26.37	3.47	2.78	2.08	0.69	2.08	0.00	0.69	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	19.22	4.98	1.03	0.34	0.34	0.34	0.17	0.17	0.51	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	32.78	3.45	1.73	2.07	1.84	0.58	0.81	0.81	0.81	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	33.42	5.70	1.19	1.72	0.80	1.72	0.93	0.66	0.13	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	37.68	5.81	2.57	2.43	1.08	1.49	1.22	1.08	0.27	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	41.26	6.40	3.27	1.42	1.42	1.71	1.56	0.71	0.57	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	32.61	4.94	0.99	0.66	1.32	0.99	0.33	1.32	0.99	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	36.12	6.50	1.66	1.80	0.83	0.83	0.69	0.28	0.55	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	34.21	3.49	2.44	3.49	1.75	1.05	0.70	1.75	1.40	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	30.01	4.08	0.82	2.25	1.43	1.43	1.84	0.41	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	34.15	5.39	5.03	2.16	2.88	0.72	1.80	2.52	1.08	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	21.00	5.17	1.03	1.03	0.72	0.93	0.62	0.21	0.31	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	26.45	5.24	3.19	1.60	3.19	2.05	2.28	1.37	0.91	1.37
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	76.78	13.43	0.84	5.87	3.78	2.10	2.94	1.26	2.10	2.52
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	44.98	6.13	1.94	1.79	1.34	1.49	1.05	0.30	0.90	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	26.35	5.25	2.19	1.84	1.40	1.49	0.96	0.53	0.35	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	40.50	8.47	0.37	1.10	0.00	1.84	0.74	1.47	2.58	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	36.63	8.01	6.01	3.43	3.43	4.86	2.00	4.58	2.58	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	77.05	10.53	4.21	10.10	6.32	5.05	3.37	4.63	2.11	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	21.92	1.83	1.37	1.37	0.91	0.46	0.00	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	26.35	2.56	1.28	2.05	2.81	0.77	1.02	0.26	0.26	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	31.67	1.05	2.62	0.52	1.31	1.83	0.52	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	26.80	4.01	4.01	2.46	1.54	1.23	2.77	0.92	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	30.83	2.35	2.12	3.06	1.65	1.41	0.00	1.41	0.94	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	26.40	4.06	2.71	1.02	0.68	0.00	0.68	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	20.83	2.36	3.93	1.57	1.18	0.79	1.18	1.57	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	21.78	6.49	0.93	2.32	0.46	0.93	1.39	0.00	1.39	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	32.01	2.60	2.02	3.17	2.31	1.15	0.87	0.58	1.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	26.77	3.35	0.89	1.78	2.68	1.34	0.67	0.22	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	22.83	2.40	1.44	1.44	0.24	1.68	0.72	0.24	1.20	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	34.47	3.67	0.73	0.73	0.00	0.00	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	24.84	3.02	1.01	2.35	0.34	0.67	0.67	0.34	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	23.33	0.82	2.05	2.05	2.46	2.87	0.00	0.41	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	22.34	3.01	0.43	1.29	3.01	0.86	2.15	0.00	0.86	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	30.08	5.47	0.00	0.00	2.73	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	0.00	5.16	5.16	0.00	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	24.03	2.60	1.30	2.27	0.32	0.65	1.95	0.65	1.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	26.19	5.82	0.00	0.00	0.00	2.91	2.91	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	25.05	2.13	1.60	0.53	0.53	1.07	1.07	1.60	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	17.17	2.45	3.27	0.82	4.09	0.82	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	20.21	2.72	0.78	1.55	2.33	1.17	0.00	1.55	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	4.20	2.10	0.00	2.10	2.10	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	26.82	1.99	0.99	1.99	1.99	0.99	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	0.00	4.77	0.00	0.00	4.77	0.00	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	17.20	4.15	0.59	0.59	0.00	1.19	1.19	0.00	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	28.02	0.00	1.22	1.22	0.00	1.22	2.44	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	22.80	1.27	0.63	0.00	2.53	1.27	0.63	0.00	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	23.11	2.07	0.69	0.69	1.03	0.34	1.38	1.03	2.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	0.00	6.45	0.00	0.00	0.00	2.15	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	11.98	3.99	0.00	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	0.00	0.00	0.00	6.89	0.00	3.44	6.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	31.38	2.85	4.48	2.44	3.67	2.04	0.81	2.44	1.63	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	30.19	3.97	0.79	3.97	3.18	0.79	1.59	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	25.94	1.77	5.31	5.90	3.54	2.36	0.59	1.77	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	20.88	3.12	2.18	3.43	1.56	0.31	0.94	2.49	0.94	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	34.75	4.01	4.01	5.35	2.67	0.00	2.67	2.67	1.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	24.84	3.55	2.37	11.83	3.55	2.37	1.18	3.55	1.18	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	41.09	5.14	15.41	17.98	0.00	10.27	5.14	2.57	10.27	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	47.50	3.44	12.39	8.95	2.07	3.44	3.44	0.69	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	29.69	2.97	3.46	6.93	3.96	1.98	0.49	3.46	1.98	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	22.43	5.61	3.36	2.24	3.36	1.12	2.24	2.24	2.24	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	27.99	2.54	9.54	6.36	2.54	3.18	1.91	1.27	1.91	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	9.67	1.61	1.21	0.40	0.81	0.40	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	0.00	0.00	0.00	0.00	0.00	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	7.60	1.27	1.27	2.53	1.27	0.00	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.24	2.43	1.82	1.82	0.61	1.21	1.21	0.61	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	18.08	22.59	0.00	13.56	4.52	9.04	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	25.53	4.12	6.59	10.71	7.41	1.65	4.94	2.47	0.00	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	24.41	2.58	1.19	0.99	0.20	0.00	0.40	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	26.61	2.60	1.30	3.24	0.65	0.97	0.32	0.65	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	28.52	1.02	6.11	5.09	3.06	3.06	3.06	3.06	3.06	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	64.22	6.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	81.74	20.32	0.71	0.71	0.94	1.18	0.94	0.71	0.94	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	83.87	8.80	1.85	2.78	0.70	2.09	1.85	0.46	0.93	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	59.83	17.09	17.09	4.27	4.27	4.27	4.27	0.00	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	53.33	7.40	2.98	2.77	2.36	0.72	1.34	1.95	0.62	0.82
mesothelioma cell line:Mero-25	10850-111F4	19.74	6.81	3.63	1.59	1.13	2.27	1.36	1.59	0.68	0.68
mesothelioma cell line:Mero-41	10851-111F5	47.43	8.07	6.36	3.91	5.62	3.67	3.67	1.96	1.47	1.22
mesothelioma cell line:Mero-48a	10852-111F6	29.45	4.65	5.76	2.21	1.55	3.54	2.21	1.99	1.33	2.21
mesothelioma cell line:Mero-82	10853-111F7	54.14	8.41	11.56	11.56	7.10	8.67	6.04	4.20	3.68	3.15
mesothelioma cell line:Mero-83	10854-111F8	73.37	8.51	13.96	10.21	8.17	10.04	4.26	4.77	2.89	3.57
mesothelioma cell line:Mero-84	10855-111F9	23.00	2.53	2.27	1.52	1.52	1.26	0.76	1.26	0.51	0.76
mesothelioma cell line:Mero-95	10856-111G1	42.24	5.59	4.97	2.07	2.07	2.69	2.28	1.24	0.41	1.86
mesothelioma cell line:NCI-H2052	10847-111F1	38.93	9.11	7.12	4.14	3.31	4.47	3.81	2.82	1.66	1.66
mesothelioma cell line:NCI-H226	10846-111E9	57.56	8.14	10.32	5.79	5.07	6.15	2.53	2.90	1.27	2.17
mesothelioma cell line:NCI-H2452	10848-111F2	45.78	5.47	6.15	3.59	4.78	3.93	1.54	2.05	2.90	1.88
mesothelioma cell line:NCI-H28	10845-111E8	57.51	8.91	9.92	5.34	5.34	3.56	5.09	3.31	3.05	2.80
mesothelioma cell line:No36	10857-111G2	28.38	6.52	2.94	1.96	4.89	3.26	1.63	2.28	1.63	1.96
mesothelioma cell line:ONE58	10858-111G3	32.24	5.15	4.06	3.79	3.52	4.61	2.44	1.08	0.81	1.08
migratory langerhans cells, donor1	11901-125F2	57.38	12.28	1.34	1.34	1.34	2.30	0.96	0.58	1.15	0.00
migratory langerhans cells, donor2	11902-125F3	37.49	7.45	0.61	0.61	0.24	0.73	0.73	0.00	0.24	0.37
migratory langerhans cells, donor3	11903-125F4	61.92	12.20	2.15	0.54	0.90	1.44	0.72	0.18	1.26	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	45.71	16.00	10.77	7.84	9.14	5.88	3.59	6.20	3.59	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	70.36	6.36	4.24	5.93	4.03	1.70	2.54	2.33	1.06	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	97.90	23.73	2.53	1.61	2.07	2.53	2.76	0.23	2.53	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	60.70	6.28	6.28	2.47	2.47	2.47	1.33	1.71	0.76	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	200.13	30.12	6.10	3.70	5.36	5.17	3.70	2.40	2.96	1.85
myeloma cell line:PCM6	10474-106I6	49.02	8.10	4.55	2.17	1.19	1.19	1.58	1.58	0.59	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	95.37	8.62	2.54	1.01	3.04	1.52	4.06	1.01	1.01	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	53.55	6.47	3.92	2.16	2.35	4.12	1.77	0.78	1.37	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	15.27	11.59	0.00	0.45	0.11	0.22	0.33	0.00	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	18.09	10.96	0.29	0.22	0.07	0.15	0.15	0.15	0.15	0.07
nasal epithelial cells, donor2	12227-129F4	24.84	7.18	0.00	0.55	2.76	2.76	0.55	0.00	1.66	0.00
neuroblastoma cell line:CHP-134	10508-107D4	213.96	31.06	2.30	1.15	3.22	2.99	2.76	1.38	2.07	1.38
neuroblastoma cell line:NB-1	10539-107G8	264.91	44.34	9.73	4.86	2.25	4.12	4.49	1.87	2.06	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	135.39	21.72	16.45	15.18	9.49	11.81	4.85	6.75	3.37	4.01
neuroblastoma cell line:NH-12	10555-107I6	290.52	48.45	35.78	22.73	19.75	19.38	11.37	11.74	8.01	6.89
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	210.42	27.28	27.28	16.84	15.42	12.81	16.84	9.96	5.46	4.74
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	115.46	30.57	12.35	8.87	6.18	5.23	6.02	4.12	1.74	1.74
neuroectodermal tumor cell line:TASK1	10774-110F9	150.14	16.70	12.28	13.08	7.04	8.25	8.25	9.26	3.42	2.62
neuroepithelioma cell line:SK-N-MC	10728-110A8	139.23	17.17	1.91	2.54	2.54	3.81	0.64	0.64	2.54	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	31.14	2.40	1.06	1.33	0.53	0.27	0.27	0.53	0.27	0.53
neutrophil PMN, donor1	12133-128D9	208.25	74.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	92.96	13.28	0.00	0.00	0.00	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	37.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	542.71	95.21	28.07	14.71	16.07	11.50	14.54	10.49	6.93	3.72
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	67.24	10.41	0.00	0.00	0.80	0.00	0.00	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	28.21	3.53	1.60	2.56	1.28	0.64	0.32	0.64	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	34.16	4.20	3.42	1.84	2.36	2.10	1.05	1.58	0.79	0.79
nucleus accumbens, adult, pool1	10037-101F1	65.90	10.31	2.34	1.12	1.12	1.31	1.03	0.56	1.12	0.56
occipital cortex - adult, donor10196	10172-103C1	140.11	14.42	16.48	8.24	2.06	6.18	6.18	2.06	4.12	4.12
occipital cortex, adult, donor10252	10163-103B1	158.33	28.71	10.20	5.10	8.32	4.29	10.47	3.76	5.10	4.29
occipital cortex, newborn, donor10223	10355-105E4	58.96	12.74	3.64	1.09	1.09	1.46	2.18	0.00	1.09	1.46
occipital lobe, adult, donor1	10076-102A4	39.36	8.92	0.00	0.79	1.05	2.62	0.26	0.00	1.84	2.10
occipital lobe, fetal, donor1	10073-102A1	71.23	23.60	3.00	2.15	4.29	6.44	4.72	2.57	2.57	3.00
occipital pole, adult, pool1	10036-101E9	31.77	6.62	0.79	0.16	0.71	0.39	0.63	0.24	0.32	0.08
olfactory region, adult	10195-103E6	87.50	11.46	18.15	9.55	8.22	7.83	8.02	2.87	4.20	3.82
optic nerve, donor1	10277-104E7	152.08	38.02	4.00	0.00	10.01	4.00	6.00	6.00	6.00	6.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	94.77	13.21	2.51	2.39	2.28	3.19	1.59	1.59	1.14	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	154.83	40.12	4.12	2.47	2.61	2.34	2.06	1.51	0.69	1.37
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	138.00	17.27	15.24	13.04	6.94	9.48	8.30	6.94	5.42	4.40
oral squamous cell carcinoma cell line:SAS	10544-107H4	83.51	16.98	8.32	8.43	5.08	4.50	4.62	5.31	2.43	1.85
osteoclastoma cell line:Hs 706.T	10704-109H2	20.28	3.23	2.65	2.94	1.18	2.06	0.59	0.29	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	231.72	65.40	1.87	0.00	0.93	1.87	1.87	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	93.94	10.60	3.18	1.70	1.48	2.12	1.27	1.06	1.91	0.85
ovary, adult, pool1	10020-101D2	71.80	15.99	2.71	1.31	0.79	0.61	0.79	0.44	0.70	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	63.06	11.92	4.22	3.48	3.12	2.20	1.28	1.28	1.47	1.28
pancreas, adult, donor1	10049-101G4	21.63	10.35	3.76	0.00	3.76	0.00	0.94	0.94	2.82	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	78.27	9.50	7.27	7.27	6.15	5.87	3.63	1.40	3.63	4.47
papillary adenocarcinoma cell line:8505C	10437-106E5	73.59	11.75	14.65	12.27	8.01	7.84	8.86	7.50	2.90	3.07
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	93.06	13.91	1.16	0.99	1.49	1.32	0.83	0.83	1.16	0.33
paracentral gyrus, adult, pool1	10035-101E8	60.40	11.35	2.20	0.73	1.10	1.10	1.92	0.46	0.82	0.55
parietal cortex, adult, donor10258	10373-105G4	61.66	11.01	15.41	5.87	7.34	7.34	4.40	0.73	2.20	3.67
parietal lobe - adult, donor10196	10171-103B9	85.58	5.64	7.52	3.76	10.35	5.64	7.52	0.94	2.82	3.76
parietal lobe, adult, donor10252	10157-103A4	114.87	18.53	8.27	5.70	9.12	5.99	11.12	4.28	4.85	1.71
parietal lobe, adult, pool1	10034-101E7	52.25	8.02	1.32	1.41	1.15	0.70	0.70	0.44	0.35	0.26
parietal lobe, fetal, donor1	10072-101I9	118.32	24.25	15.52	14.55	10.67	4.85	11.64	0.97	2.91	4.85
parietal lobe, newborn, donor10223	10356-105E5	67.67	10.84	2.99	0.37	3.36	1.87	1.50	0.75	0.37	1.12
parotid gland, adult	10199-103F1	45.02	4.93	8.02	2.47	1.85	3.08	1.85	0.62	0.62	1.23
penis, adult	10200-103F2	73.05	14.50	11.82	7.52	5.91	10.21	4.30	1.61	3.22	4.30
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	39.79	24.36	5.21	3.72	3.72	4.28	2.42	1.67	1.67	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	61.77	10.20	8.45	6.26	4.81	4.23	4.66	2.77	1.60	1.89
pineal gland - adult, donor10196	10179-103C8	121.91	15.48	1.94	0.65	5.16	3.87	4.52	1.94	3.87	1.29
pineal gland, adult, donor10252	10160-103A7	218.53	24.28	11.25	4.15	7.70	5.33	5.92	1.18	4.15	2.37
pineal gland, adult, donor10258	10377-105G8	65.22	11.91	6.90	0.63	5.64	3.14	5.02	0.00	1.88	0.63
pituitary gland - adult, donor10196	10180-103C9	152.78	15.18	16.19	5.06	17.20	10.12	11.13	4.05	12.14	12.14
pituitary gland, adult, donor10252	10162-103A9	329.91	47.43	13.03	7.30	9.38	7.30	11.47	4.69	3.13	5.73
pituitary gland, adult, donor10258	10378-105G9	90.23	17.88	14.47	6.81	4.26	3.40	6.81	2.55	4.26	2.55
placenta, adult, pool1	10021-101D3	59.13	5.70	2.04	1.18	0.32	0.97	0.75	0.54	0.65	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	133.75	32.31	10.86	5.30	7.55	5.16	3.97	3.31	2.52	2.12
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	51.52	8.56	1.09	0.78	0.93	1.25	0.62	0.47	0.78	0.47
pons, adult, pool1	10033-101E6	91.32	14.55	2.41	1.98	1.55	1.38	1.03	0.77	0.60	0.43
postcentral gyrus, adult, pool1	10032-101E5	34.96	4.88	1.22	0.61	0.70	0.78	0.35	0.26	0.52	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	598.14	102.48	0.00	0.00	0.00	0.00	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	11.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	122.79	20.68	9.91	5.83	6.41	4.95	5.54	4.08	3.06	2.62
prostate cancer cell line:PC-3	10439-106E7	157.91	20.87	12.89	8.53	7.62	9.80	9.62	5.81	5.63	3.99
prostate, adult, pool1	10022-101D4	67.20	11.79	1.90	0.73	1.00	0.36	1.00	0.09	0.63	0.45
putamen, adult, donor10196	10176-103C5	120.39	16.52	14.64	5.90	8.50	5.43	7.08	4.49	4.96	4.01
putamen, adult, donor10252	10152-102I8	101.96	9.80	0.00	3.92	1.96	0.00	9.80	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	104.91	6.56	18.58	8.74	3.28	6.56	4.37	3.28	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	67.65	9.91	14.98	4.11	7.01	6.04	6.04	3.38	3.87	1.93
putamen, newborn, donor10223	10365-105F5	117.70	23.99	7.50	3.00	5.25	3.00	3.00	3.00	1.50	0.75
rectal cancer cell line:TT1TKB	10469-106I1	399.74	46.26	15.42	3.78	5.53	3.49	11.35	2.62	3.49	3.49
rectum, fetal, donor1	10067-101I4	80.68	26.43	5.56	1.39	1.39	0.00	6.95	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	46.64	4.66	1.48	1.27	0.42	0.85	0.42	1.48	0.85	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	19.05	6.63	2.07	0.41	1.66	0.41	1.66	0.41	0.83	0.83
retina, adult, pool1	10030-101E3	61.73	11.93	1.49	0.70	1.49	0.99	0.99	0.40	0.30	0.50
retinoblastoma cell line:Y79	10475-106I7	359.05	52.48	27.28	15.07	23.64	15.33	16.11	10.65	10.91	10.39
rhabdomyosarcoma cell line:KYM-1	10787-110H4	150.73	27.42	11.07	7.38	9.71	7.25	9.96	4.67	4.06	3.32
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	300.88	46.96	7.59	1.97	3.66	3.37	3.09	1.69	3.09	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	40.92	9.09	2.27	0.00	0.76	0.76	0.76	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	57.78	15.70	9.55	3.88	5.66	4.86	3.08	1.62	2.10	1.78
salivary acinar cells, donor2	11772-123I8	76.97	10.88	11.84	6.75	4.13	6.33	4.27	1.93	3.03	3.72
salivary acinar cells, donor3	11773-123I9	124.47	26.48	5.30	5.30	1.99	3.31	3.97	0.66	1.32	2.65
salivary gland, adult, pool1	10093-102C3	33.75	4.00	1.14	0.00	0.57	0.57	0.00	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	58.26	11.55	2.11	2.02	1.69	0.93	1.35	0.84	0.59	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	55.37	11.28	2.94	2.47	2.70	1.53	2.47	1.88	1.06	1.18
seminal vesicle, adult	10201-103F3	57.67	12.70	8.99	3.17	6.35	8.47	6.35	3.17	5.29	5.29
serous adenocarcinoma cell line:JHOS-2	10639-108I9	169.08	14.58	10.69	11.66	6.32	6.56	4.37	4.62	2.92	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	26.92	2.52	1.26	0.50	0.50	0.25	0.25	1.01	0.25	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	41.14	4.01	6.02	2.01	2.01	3.01	1.00	0.00	3.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	92.95	13.57	10.75	7.92	6.18	8.73	5.64	3.36	2.69	2.42
signet ring carcinoma cell line:Kato III	10436-106E4	92.40	20.89	3.98	2.21	2.54	2.65	1.88	2.21	0.88	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	90.96	12.00	2.19	1.03	0.65	1.42	1.16	0.90	0.39	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	90.09	22.70	4.97	2.13	4.26	7.80	9.22	4.97	2.84	4.97
skeletal muscle, adult, pool1	10023-101D5	35.86	15.83	1.56	0.72	0.96	1.20	0.84	0.00	0.36	0.00
skeletal muscle, fetal, donor1	10066-101I3	16.08	4.02	0.00	0.00	3.02	0.00	1.01	0.00	1.01	1.01
skin, adult, donor1	10074-102A2	20.36	13.57	0.00	0.00	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	80.17	22.09	1.89	0.63	0.63	7.57	1.89	1.26	6.31	4.42
small cell cervical cancer cell line:HCSC-1	10800-110I8	99.06	23.01	10.67	6.00	4.34	6.67	5.00	2.67	1.33	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	278.33	50.43	44.76	33.10	22.69	24.59	23.33	17.02	17.97	8.83
small cell lung carcinoma cell line:DMS 144	10841-111E4	122.20	23.32	3.28	7.52	2.31	3.47	3.08	1.35	1.54	2.31
small cell lung carcinoma cell line:LK-2	10541-107H1	176.53	33.95	4.45	2.97	3.13	3.46	1.98	1.48	1.65	1.65
small cell lung carcinoma cell line:NCI-H82	10842-111E5	218.59	170.34	40.21	21.07	21.39	17.05	20.91	13.51	11.58	6.76
small cell lung carcinoma cell line:WA-hT	10562-108A4	154.72	11.99	14.60	9.37	6.54	8.50	5.88	5.88	2.83	3.49
small intestine, adult, pool1	10024-101D6	83.37	11.11	1.91	1.31	1.67	0.84	1.91	0.60	0.96	0.96
small intestine, fetal, donor1	10064-101I1	66.34	11.55	11.30	6.63	6.63	6.88	6.39	3.19	3.44	5.16
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	51.29	15.39	6.67	7.18	2.05	2.05	4.10	2.56	2.56	1.54
smooth muscle, adult, pool1	10048-101G3	79.60	12.41	7.75	4.39	4.39	3.10	5.94	1.29	1.03	2.33
somatostatinoma cell line:QGP-1	10781-110G7	59.77	15.01	1.34	0.54	1.61	0.27	1.07	0.54	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	101.17	22.94	9.41	3.67	4.82	3.44	6.88	1.15	1.61	2.06
spinal cord, adult, donor10252	10159-103A6	174.27	39.03	10.25	3.94	5.52	6.70	6.70	4.73	4.73	3.15
spinal cord, adult, donor10258	10369-105F9	141.13	14.53	19.37	11.07	6.92	4.84	7.61	6.92	3.46	2.77
spinal cord, fetal, donor1	10056-101H2	69.52	11.59	4.27	1.22	4.27	6.10	9.15	2.44	2.44	3.66
spinal cord, newborn, donor10223	10359-105E8	123.99	20.66	8.27	4.13	4.59	1.38	5.05	4.13	3.21	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	43.46	7.77	2.39	1.19	1.49	0.90	1.19	0.30	1.05	0.15
spleen, adult, pool1	10025-101D7	66.63	10.57	1.10	1.43	0.44	0.99	1.43	0.44	0.66	0.22
spleen, fetal, pool1	10044-101F8	62.21	11.04	0.64	0.40	0.56	0.40	0.48	0.16	0.16	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	93.37	12.42	6.62	3.31	4.14	3.62	2.59	2.38	1.55	1.55
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	113.55	17.09	8.73	2.28	3.99	4.37	5.89	2.85	1.52	1.33
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	121.26	6.64	17.12	13.98	9.44	8.39	11.88	5.94	3.84	2.45
squamous cell carcinoma cell line:T3M-5	10616-108G4	73.10	26.19	3.13	3.52	1.56	2.35	1.17	2.74	0.78	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	114.70	19.02	7.77	4.50	4.16	3.71	3.15	3.15	1.80	1.69
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	63.12	11.44	3.39	1.69	3.39	3.81	1.69	1.69	1.69	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	86.31	12.27	4.23	1.69	2.54	2.54	2.12	2.12	0.00	0.85
stomach, fetal, donor1	10062-101H8	140.97	17.09	4.27	3.20	0.00	3.20	2.14	0.00	2.14	1.07
submaxillary gland, adult	10202-103F4	78.05	17.09	1.71	1.71	6.27	5.70	6.84	1.71	7.41	4.56
substantia nigra - adult, donor10196	10178-103C7	1682.50	162.82	1736.77	542.74	976.93	542.74	759.84	162.82	325.64	162.82
substantia nigra, adult, donor10252	10158-103A5	141.86	26.59	14.12	7.69	11.63	9.97	10.39	4.78	7.06	6.23
substantia nigra, adult, donor10258	10371-105G2	67.76	7.76	12.41	5.17	7.24	5.69	6.21	1.03	2.07	3.62
substantia nigra, newborn, donor10223	10358-105E7	45.93	3.53	0.71	0.71	2.12	0.71	0.00	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	131.83	18.11	12.84	7.80	7.34	8.02	8.71	6.19	2.98	2.98
temporal lobe, adult, pool1	10031-101E4	32.21	5.51	1.19	0.59	0.59	0.42	0.25	0.17	0.17	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	95.44	27.78	6.41	0.71	9.97	9.97	6.41	4.27	2.85	7.12
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	87.47	21.10	7.03	0.88	6.59	8.35	5.71	3.08	6.15	7.91
tenocyte, donor1	11763-123H8	35.96	2.79	5.93	7.68	3.14	3.49	2.79	3.84	2.44	2.09
tenocyte, donor2	11765-123I1	21.75	4.96	2.29	5.72	3.43	2.29	1.14	2.29	1.14	1.91
tenocyte, donor3	11768-123I4	27.80	3.71	4.82	7.41	3.71	5.93	1.85	4.45	2.97	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	177.10	20.40	17.17	13.09	10.71	11.56	3.91	6.29	3.57	4.93
teratocarcinoma cell line:NCR-G1	10798-110I6	150.60	15.11	9.56	7.86	5.86	8.17	4.93	4.62	3.85	3.85
teratocarcinoma cell line:PA-1	10807-111A6	120.26	22.16	11.31	7.44	8.83	8.06	7.28	5.42	4.18	2.32
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	106.26	13.58	8.51	3.05	4.57	4.57	4.19	3.17	3.81	1.27
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	217.07	31.77	15.51	6.05	10.59	5.67	7.56	3.03	4.16	3.03
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	172.86	49.51	9.27	3.71	4.91	5.13	4.47	2.29	1.85	2.29
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	139.08	33.22	24.43	18.57	12.05	12.70	13.03	7.49	5.21	7.17
testis, adult, pool1	10026-101D8	46.17	13.85	2.25	0.75	0.75	0.64	0.54	0.54	0.21	0.32
testis, adult, pool2	10096-102C6	50.97	23.01	11.73	7.67	6.77	5.41	5.86	4.06	1.35	3.61
thalamus - adult, donor10196	10168-103B6	97.15	25.39	9.94	2.21	1.10	5.52	3.31	2.21	0.00	4.42
thalamus, adult, donor10252	10154-103A1	172.07	33.29	15.78	6.72	8.75	8.44	11.56	3.13	4.22	4.84
thalamus, adult, donor10258, tech_rep1	10370-105G1	104.69	3.08	9.24	3.08	4.62	6.16	3.08	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	30.14	5.76	4.28	2.80	1.32	0.66	2.31	0.82	0.16	0.33
thalamus, newborn, donor10223	10366-105F6	36.82	6.33	1.73	0.58	1.15	0.58	1.15	0.00	0.58	0.58
throat, adult	10209-103G2	79.39	17.98	0.75	1.00	3.50	4.74	3.99	0.75	3.99	1.50
throat, fetal, donor1	10061-101H7	69.17	13.10	8.23	5.18	3.96	5.18	6.40	3.35	2.74	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	190.39	36.96	6.96	5.37	8.15	5.56	5.17	4.97	2.98	3.58
thymus, adult, pool1	10027-101D9	96.33	11.43	1.39	0.80	1.39	1.19	1.49	0.50	0.89	0.20
thymus, fetal, pool1	10043-101F7	181.31	26.81	3.95	1.77	1.97	2.39	1.87	0.52	1.35	1.04
thyroid carcinoma cell line:KHM-5M	10776-110G2	48.40	9.31	1.86	2.66	1.46	1.99	1.20	1.46	0.80	1.33
thyroid carcinoma cell line:TCO-1	10783-110G9	117.48	22.21	14.95	10.90	9.50	7.96	8.66	5.59	3.49	3.21
thyroid, adult, pool1	10028-101E1	61.12	17.54	1.96	1.77	0.75	0.93	1.31	0.56	0.47	0.56
thyroid, fetal, donor1	10060-101H6	78.57	12.92	10.81	11.07	6.59	5.27	7.65	3.95	3.95	4.48
tongue epidermis (fungiform papillae), donor1	10288-104F9	172.46	24.64	3.08	0.00	15.40	3.08	9.24	0.00	3.08	6.16
tongue, adult	10203-103F5	62.10	8.14	6.51	4.42	3.26	2.33	4.65	1.86	3.49	1.86
tongue, fetal, donor1	10059-101H5	47.69	11.43	5.91	2.76	1.97	3.55	3.94	2.76	3.94	1.97
tonsil, adult, pool1	10047-101G2	70.82	10.02	1.30	0.50	0.40	0.40	0.50	0.10	0.30	0.00
trachea, adult, pool1	10029-101E2	55.95	11.53	1.15	0.98	0.74	0.90	0.41	0.33	0.65	0.16
trachea, fetal, donor1	10058-101H4	61.17	8.85	3.85	2.69	1.92	1.92	2.31	1.15	0.38	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	32.24	5.67	4.61	3.19	3.54	1.42	2.83	2.13	1.77	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	149.95	20.47	3.14	1.22	2.03	1.82	1.32	1.72	1.01	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	145.41	27.26	10.03	7.52	5.95	4.54	6.11	3.76	3.29	3.29
tridermal teratoma cell line:HGRT	10694-109G1	58.98	9.51	1.90	0.00	0.00	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	42.41	8.97	3.30	2.96	1.95	2.71	2.12	1.78	0.93	1.27
umbilical cord, fetal, donor1	10057-101H3	47.99	14.61	10.43	8.35	6.26	6.26	2.09	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	74.05	12.80	1.19	0.85	1.54	1.37	0.51	0.51	1.02	0.85
uterus, fetal, donor1	10055-101H1	71.16	15.36	3.58	6.66	3.58	3.07	3.58	2.05	0.51	2.05
vagina, adult	10204-103F6	76.90	30.37	2.58	0.00	0.00	0.00	1.94	0.65	0.65	1.29
vein, adult	10191-103E2	66.42	12.71	1.97	1.75	3.29	1.53	3.07	1.53	0.88	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	86.79	8.81	6.94	10.15	4.54	5.34	3.20	4.54	4.01	1.60